Suche





:

Adriaenssens T, Delcroix M, Van Deyk K, Budts W: Advanced therapy may delay the need for transplantation in patients with the Eisenmenger syndrome. Eur Heart J.2006 Jun;27(12):1472-7

Adriaenssens T, Ibrahim T, Seyfarth M: The LEOPARD syndrome a rare condition associated with hypertrophic cardiomyopathy. Eur Heart J. 2007 Dec;28(24):3066. Epub 2007 Jul 27

Adriaenssens T, Kastrati A, Schoemig A: Successful stenting of bilateral multiple renal arteries in a patient with renovascular hypertension. J Invasive Cardiol. 2007 Aug;19(8):E235-7

Adriaenssens T, Mehilli J, Wessely R, Ndrepepa G, Seyfarth M, Wieczorek A, Blaich B, Iijima R, Pache J, Kastrati A, Schoemig A: Does addition of estradiol improve the efficacy of a rapamycin-eluting stent? Results of the ISAR-PEACE randomized trial. J Am Coll Cardiol. 2007 Mar 27;49(12):1265-71. Erratum in J Am Coll Cardiol. 2007 May 8;49(18):1902

Ammer R, Lehmann G, Plewan A, Puetter K: Marked reduction in atrial defibrillation thresholds with repeated internal cardioversion. J Am Coll Cardiol 1999; 5:1569-76

Anderson KM, Califf RM, Stone GW, Neumann FJ, Montalescot G, Miller DP, Ferguson III JJ, Willerson JT, Weisman HF, Topol EJ: Long-term mortality benefit with abciximab with abciximab in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol 37 (2001). 2059-2065

Andrassy P, Zielinska M, Busch R, Schoemig A, Firschke C: Myocardial blood volume and the amount of viable myocardium early after mechanical reperfusion of acute myocardial infarction. prospective study using venous contrast echocardiography. Heart. 2002 Apr;87(4).350-5

Andrassy P, Zielinska M, Firschke C: Detection of myocardial viability with venous contrast echocardiography immediately after reperfusion therapy in patients with AMI. Orv Hetil. 2002 Aug;143(31).1847-51. Hungarian

Antl M, V Bruhl ML, Eiglsperger C, Werner M, Konrad I, Kocher T, Wilm M,Hofmann F, Massberg S, Schlossmann J: IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation. Blood 2006 Sep 21

Antl M, von Brühl ML, Eiglsperger C, Werner M, Konrad I, Kocher T, Wilm M, Hofmann F, Massberg S, Schlossmann: IRAG mediates NO/cGMP-dependent inhibition of platelet aggregation and thrombus formation. Blood. 2007 Jan 15;109(2):552-9

Augustin N, Bauernschmitt R, Hausleiter J, Lange R: Dislocation of a stent-graft into the aortic arch during endovascular repair ofa descending thoracic aortic aneurysm. Ann Thorac Surg. 2006 Apr;81(4):1502-5

Augustin N, Wessely R, Porner M, Schoemig A, Lange R: Giant coronary aneurysm obstructing the right heart. Lancet. 2006 Jul 29;368(9533):386

Bai R, Patel D, Di Biase L, Fahmy TS, Kozeluhova M, Prasad S, Schweikert R, Cummings J, Saliba W, Andrews-Williams M, Themistoclakis S, Bonso A, Rossillo A, Raviele A, Schmitt C, Karch M, Uriarte JA, Tchou P, Arruda M, Natale A: Phrenic nerve injury after catheter ablation: should we worry about this complication?. J Cardiovasc Electrophysiol.2006 Sep;17(9):944-8

Bajraktari G, Koltai MS, Ademaj F, Rexhepaj N, Qirko S, Ndrepepa G, Elezi S: Relationship between insulin resistance and left ventricular diastolic dysfunction in patients with impaired glucose tolerance and type 2 diabetes. Int J Cardiol.2006 Jun 16;110(2):206-11.Epub 2005 Nov 17

Bajraktari G, Qirko S, Rexhepaj N, Bakalli A, Beqiri A, Elezi S, Ndrepepa G: Non-insulin dependent diabetes as an independent predictor of asymptomatic left ventricular diastolic dysfunction. Croat Med J. 2005;46:225-31

Barthel P, Schneider R, Bauer A, Ulm K, Schmitt C, Schoemig A, Schmidt G: Risk Stratification After Acute Myocardial Infarction by Heart Rate Turbulence. Circulation. 2003;108:1221-1226.

Bary CV, Liebig T, Gaa J, von Beckerath N: Ischaemic stroke and myocardial infarction in a Caucasian patient with Moya Moya disease. Eur Heart J. 2007 Nov 6

Bauer A, Deisenhofer I, Schneider R, Zrenner B, Barthel P, Karch M, Wagenpfeil S, Schmitt C, Schmidt G: Effects of circumferential or segmental pulmonary vein ablation for paroxysmalatrial fibrillation on cardiac autonomic function. Heart Rhythm.2006 Dec;3(12):1428-35

Bauer A, Guzik P, Barthel P, Schneider R, Ulm K, Watanabe MA, Schmidt G: Reduced prognostic power of ventricular late potentials in post-infarction patients of the reperfusion era. Eur Heart J. 2005;26:755-61

Bauer A, Kantelhardt JW, Barthel P, Schneider R, Makikallio T, Ulm K, Hnatkova K, Schoemig A, Huikuri H, Bunde A, Malik M, Schmidt G: Deceleration capacity of heart rate as a predictor of mortality aftermyocardial infarction: cohort study. Lancet.2006 May 20;367(9523):1674-81

Bauer A, Kantelhardt JW, Bunde A, Malik M, Schneider R, Schmidt G: Phase-rectified signal averaging detects quasi-periodicities in non-stationary data. Physica A. 2006; 364: 423-434

Bauer A, Malik M, Barthel P, Schneider R, Watanabe MA, Camm AJ, Schoemig A, Schmidt G: Turbulence dynamics: an independent predictor of late mortality after acutemyocardial infarction. Int J Cardiol. 2006 Feb 8;107(1):42-7

Bauer A, Schmidt G: Last piece of the heart rate turbulence puzzle? Heart Rhythm. 2007 Mar;4(3):290-1. Epub 2006 Nov 10

Bauer A, von Bary C, Dorn J, Dennig K: Giant free floating left atrial thrombus. Eur J Cardiothorac Surg. 2005;28:164

Bauer A, Watanabe MA, Barthel P, Schneider R, Ulm K, Schmidt G: QRS duration and late mortality in unselected post-infarction patients of the revascularization era. Eur Heart J. 2006 Feb;27(4):427-33.Epub 2005 Dec 7

Baumert J, Schmitt C, Ladwig KH: Psychophysiologic and affective parameters associated with pain intensity of cardiac cardioverter defibrillator shock discharges. Psychosom Med. 2006 Jul-Aug;68(4):591-7

Baumert J, Simon H, Gundel H, Schmitt C, Ladwig KH: The Impact of Event Scale--Revised: evaluation of the subscales and correlations to psychophysiological startle response patterns in survivors of a life-threatening cardiac event: an analysis of 129 patients with an implanted cardioverter defibrillator. J Affect Disord. 2004;82:29-41.

Bengel FM, Lehnert J, Ibrahim T, Klein C, Bulow HP, Nekolla SG, Schwaiger M: Cardiac oxidative metabolism, function, and metabolic performance in mild hyperthyroidism: a noninvasive study using positron emission tomography and magnetic resonance imaging. Thyroid. 2003;13:471-7.

Bengel FM, Nekolla SG, Ibrahim T, Weniger C, Ziegler SI, Schwaiger M: Effect of thyroid hormones on cardiac function, geometry, and oxidative metabolism assessed noninvasively by positron emission tomography and magneticresonance imaging. J Clin Endocrinol Metab 2000;85.1822-1827

Bengel FM, Permanetter B, Ungerer M, Nekolla S, Schwaiger M: Non-invasive estimation of myocardial efficiency using positron emission tomography and carbon-11 acetate--comparison between the normal and failing human heart. Eur J Nucl Med. 2000;27.319-326

Besta F, Massberg S, Brand K, Mueller E, Page S, Gruner S, Lorenz M, Sadoul K, Kolanus W, Lengyel E, Gawaz M: Role of beta(3)-endonexin in the regulation of NF-kappaB-dependent expression of urokinase-type plasminogen activator receptor. J Cell Sci. 2002 Oct 15;115(Pt 20).3879-88

Besta F, Muller I, Lorenz M, Massberg S, Bultmann A, Cabeza N, Richter T, Kremmer E, Nothdurfter C, Brand K, Gawaz M: Reduced beta3-endonexin levels are associated with enhanced urokinase-type plasminogen activator receptor expression in ApoE-/- mice. Thromb Res. 2004;114:283-92.

Birkhofer A, Schmidt G, Forstl H: Heart and brain -- the influence of psychiatric disorders and their therapy on the heart rate variability. Fortschr Neurol Psychiatr. 2005;73:192-205

Birkhofer A, Schmidt G, Forstl H: Heart rate variability and depression. Arch Gen Psychiatry.2006 Sep;63(9):1052

Birkhofer VA, Schmidt G, Forstl H: Relationships between mental and cardiac diseases. MMW Fortschr Med. 2005;147:38, 40-3

Bleiziffer S, Hettich I, Eisenhauer B, Ruzicka D, Wottke M, Hausleiter J, Martinoff S, Morgenstern M, Lange R: Patency rates of endoscopically harvested radial arteries one year after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2007 Sep;134(3):649-56

Boettiger C, Kastrati A, Koch W, Mehilli J, Seidl H, Schoemig K, von Beckerath N, Schoemig A: HPA-1 and HPA-3 orphisms of the platelet fibrinogen receptor and coronary artery disease and myocardial infarction. Thromb Haemost 2000;83.559-562

Boettiger C, Kastrati A, Koch W, Mehilli J, von Beckerath N, Dirschinger J, Gawaz M, Schoemig A: Polymorphism of platelet glycoprotein IIb and risk of thrombosis and restenosis after coronary stent placement. Am J Cardiol. 1999;84:987-91

Boettiger C, Koch W, Mehilli J, Schoemig A, Kastrati A: Glycoprotein VI polymorphisms and outcome after percutaneous coronary interventions. Thromb Haemost. 2007 Apr;97(4):673-4

Bolck B, Munch G, Mackenstein P, Hellmich M, Hirsch I, Reuter H, Hattebuhr N, Weig HJ, Ungerer M, Brixius K, Schwinger RH: Na+/Ca2+ exchanger overexpression impairs frequency- and ouabain-dependent cell shortening in adult rat cardiomyocytes. Am J Physiol Heart Circ Physiol. 2004;287:H1435-45

Bott-Fluegel L, Weig HJ, Knodler M, Stadele C, Moretti A, Laugwitz KL, Seyfarth M: Gene transfer of the pancaspase inhibitor P35 reduces myocardial infarct size and improves cardiac function. J Mol Med. 2005;83:526-34

Braun S, Ndrepepa G, von Beckerath N, Mehilli J, Gorchakova O, Vogt W, Schoemig A, Kastrati A: Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting. Am Heart J. 2005;150:550-6

Braun S, Ndrepepa G, von Beckerath N, Vogt W, Schoemig A, Kastrati A: Value of serum ferritin and soluble transferrin receptor for prediction of coronary artery disease and its clinical presentations. Atherosclerosis. 2004;174:105-10

Buerke M, Rupprecht HJ, vom Dahl J, Terres W, Seyfarth M, Schultheiss HP, Richardt G, Sheehan FH, Drexler H: Sodium-hydrogen exchange inhibition. novel strategy to prevent myocardial injury following ischemia and reperfusion. Am J Cardiol 2000; 83.19G-22G

Burgdorf C, Richardt D, Kurz T, Seyfarth M, Jain D, Katus HA, Richardt G: Adenosine inhibits norepinephrine release in the postischemic rat heart. the mechanism of neuronal stunning. Cardiovasc Res 49 (2001) 713-20

Busch G, Seitz I, Steppich B, Hess S, Eckl R, Schoemig A, Ott I: Coagulation factor Xa stimulates interleukin-8 release in endothelial cells and mononuclear leukocytes: implications in acute myocardial infarction. Arterioscler Thromb Vasc Biol. 2005;25:461-6

Cannon CP, Weintraub WS, Demopoulos LA, Vicari R, Frey MJ, Lakkis N, Neumann FJ, Robertson DH, De Lucca PT, Di Battiste PM, Gibson M, Braunwald E: Comparison of early invasive versus conservative strategies in patients with unstable angina and non-ST elevation myocardial infarction treated with the glycoprotein IIb/IIIa inhibitor tirofiban. New Engl J Med 344 (2001)1879-1887

Chavakis T, Kanse SM, May AE, Preissner KT: Haemostatic factors occupy new territory. the role of the urokinase receptor system and kininogen in inflammation. Biochem Soc Trans. 2002 Apr;30(2).168-73

Chavakis T, Kanse SM, Pixley RA, May AE, Isordia-Salas I, Colman RW, Preissner KT: Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen. FASEB J 15. 2365-2376

De Luca G, Suryapranata H, Stone GW, Antoniucci D, Biondi-Zoccai G, Kastrati A, Chiariello M, Marino P: Coronary stenting versus balloon angioplasty for acute myocardial infarction. A meta-regression analysis of randomized trials. Int J Cardiol. 2007 Jun 1

Deisenhofer I: Simplified algorithm for localization of atrial macroreentrant tachycardias: keep it simple and short. Heart Rhythm.2006 May;3(5):524-5

Deisenhofer I, Estner H, Pflaumer A, Zrenner B: Atypical access to typical atrial flutter. Heart Rhythm. 2005;2:93-6

Deisenhofer I, Estner H, Zrenner B, Schreieck J, Weyerbrock S, Hessling G, Scharf K, Karch MR, Schmitt C: Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation: incidence, electrophysiological characteristics, and results of radiofrequency ablation. Europace.2006 Aug;8(8):573-82

Deisenhofer I, Kolb C, Ndrepepa G, Schreieck J, Karch M, Schmieder S, Zrenner B, Schmitt C: Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol. 2001;12:134-42.

Deisenhofer I, Schneider MA, Bohlen-Knauf M, Zrenner B, Ndrepepa G, Schmieder S, Weber S, Schreieck JJ, Weyerbrock S, Schmitt C: Circumferential mapping and electric isolation of pulmonary veins in patients with atrial fibrillation. Am J Cardiol. 2003;91:159-63.

Dennig K, Lehmann G: Thrombosis of an Aortic Valve Prosthesis. Heart, 1999, 82:653

Dennig K, Lehmann G, Richter T: An angiosarcoma in the left atrium. N Engl J Med 2000;342.443-444

Dibra A, Kastrati A, Alfonso F, Seyfarth M, Pérez-Vizcayno MJ, Mehilli J, Schoemig A: Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis. A meta-analysis of randomized trials. J Am Coll Cardiol. 2007 Feb 6;49(5):616-23

Dibra A, Kastrati A, Mehilli J, Pache J, Schuehlen H, von Beckerath N, Ulm K, Wessely R, Dirschinger J, Schoemig A: Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med. 2005;353:663-70

Dibra A, Kastrati A, Mehilli J, Pache J, von Oepen R, Dirschinger J, Schoemig A: Influence of stent surface topography on the outcomes of patients undergoing coronary stenting: a randomized double-blind controlled trial. Catheter Cardiovasc Interv. 2005;65:374-80

Dibra A, Kastrati A, Schuehlen H, Schoemig A: The relationship between hospital or operator volume and outcomes of coronary patients undergoing percutaneous coronary interventions. Z Kardiol. 2005;94:231-8

Dibra A, Mehilli J, Braun S, Hadamitzky M, Baum H, Dirschinger J, Schuehlen H, Schoemig A, Kastrati A: Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting. Am J Med. 2003;114:715-22.

Dibra A, Mehilli J, Braun S, Hadamitzky M, Baum H, Dirschinger J, Schuehlen H, Schoemig A, Kastrati A: Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting. Am Heart J. 2005;150:344-50

Dibra A, Mehilli J, Dirschinger J, Pache J, Neverve J, Schwaiger M, Schoemig A, Kastrati A: Thrombolysis in myocardial infarction myocardial perfusion grade in angiography correlates with myocardial salvage in patients with acute myocardial infarction treated with stenting or thrombolysis. J Am Coll Cardiol. 2003;41:925-9.

Dibra A, Mehilli J, Schwaiger M, Schuehlen H, Bollwein H, Braun S, Neverve J, Schoemig A, Kastrati A: Predictive value of basal C-reactive protein levels for myocardial salvage in patients with acute myocardial infarction is dependent on the type of reperfusion treatment. Eur Heart J. 2003;24:1128-33.

Dibra A, Ndrepepa G, Mehilli J, Dirschinger J, Pache J, Schuehlen H, Schoemig A, Kastrati A: Comparison of C-reactive protein levels before and after coronary stenting and restenosis among patients treated with sirolimus-eluting versus bare metal stents. Am J Cardiol. 2005;95:1238-40

Dibra A, Ndrepepa G, Mehilli J, Pineck S, Mayer S, Bollwein H, Hausleiter J, Pache J, Schoemig A, Kastrati A: Prognostic value of impaired fasting glucose for outcomes of patients with stable angina pectoris treated with percutaneous coronary interventions. Am J Cardiol. 2005;96:1113-5

Dickfeld T, Lengyel E, May AE, Massberg S, Brand K, Page S, Thielen C, Langenbrink K, Gawaz M: Transient interaction of activated platelets with endothelial cells induces expression of monocyte-chemoattractant protein-1 via a p38 mitogen-activated protein kinase mediated pathway. Implications for atherogenesis. Cardiovasc Res 49 (2001) 189-199

Dickfeld T, Ruf A, Pogatsa-Murray G, Mueller I, Engelmann B, Taubitz W, Fischer J, Meier O, Gawaz M: Differential antiplatelet effects of various glycoprotein IIb-IIIa antagonists. Thromb Res 101 (2001) 53-64

Dirschinger J, Kastrati A, Neumann FJ, Boekstegers P, Elezi S, Mehilli J, Schuehlen H, Pache J, Alt E, Blasini R, Steinbeck G, Schoemig A: Influence of Balloon Pressure During Stent Placement in Native Coronary Arteries on Early and Late Angiographic and Clinical Outcome. Circulation, 1999, 100:918-23

Dong J, Ndrepepa G, Schmitt C, Mehilli J, Schmieder S, Schwaiger M, Schoemig A, Kastrati A: Early resolution of ST-segment elevation correlates with myocardial salvage assessed by Tc-99m sestamibi scintigraphy in patients with acute myocardial infarction after mechanical or thrombolytic reperfusion therapy. Circulation. 2002 Jun 25;105(25).2946-9

Dong J, Schreieck J, Ndrepepa G, Schmitt C: Ectopic tachycardia originating from the superior vena cava. J Cardiovasc Electrophysiol. 2002 Jun;13(6).620-4

Dong J, Zrenner B, Schmitt C: Images in cardiology. Existence of muscles surrounding the persistent left superior vena cava demonstrated by electroanatomic mapping. Heart. 2002 Jul;88(1).4

Dong J, Zrenner B, Schreieck J, Deisenhofer I, Karch M, Schneider M, von Bary C, Weyerbrock S, Yin Y, Schmitt C: Catheter ablation of left atrial focal tachycardia guided by electroanatomic mapping and new insights into interatrial electrical conduction. Heart Rhythm. 2005;2:578-91

Dong J, Zrenner B, Schreieck J, Schmitt C: Necessity for biatrial ablation to achieve bidirectional cavotricuspid isthmus conduction block in a patient following senning operation. J Cardiovasc Electrophysiol. 2004;15:945-9

Drzezga AE, Blasini R, Ziegler SI, Bengel FM, Picker W, Schwaiger M: Coronary microvascular reactivity to sympathetic stimulation in patients with idiopathic dilated cardiomyopathy. J Nucl Med 2000;41.837-844

Eichhorn ME, Ney L, Massberg S, Goetz AE: Platelet kinetics in the pulmonary microcirculation in vivo assessed by intravital microscopy. J Vasc Res. 2002 Jul-Aug;39(4).330-9

Eicken A, Kolb C, Lange S, Brodherr-Heberlein S, Zrenner B, Schreiber C, Hess J: Implantable cardioverter defibrillator (ICD) in children. Int J Cardiol. 2006 Feb 8;107(1):30-5

Elezi S, Dibra A, Folkerts U, Mehilli J, Heigl S, Schoemig A, Kastrati A: Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease. J Am Coll Cardiol. 2006 Jul 18;48(2):262-7

Elezi S, Dibra A, Mehilli J, Pache J, Wessely R, Schoemig A, Kastrati A: Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents. J Am Coll Cardiol. 2006 Oct 3;48(7):1304-9

Elezi S, Dibra A, Schoemig A, Kastrati A: Current drug-eluting stents in complex patients and lesions. Minerva Cardioangiol. 2006 Feb;54(1):5-22. Review

Elezi S, Kastrati A, Hadamitzky M, Dirschinger J, Neumann FJ, Schoemig A: Clinical and Angiographic Follow-up After Balloon Angioplasty With Provisional Stenting for Coronary In-Stent Restenosis. 1999, Catheterization and Cardiovascular Interventions 48:151-6

Engelke C, Riedel M, Rummeny EJ, Marten K: Pulmonary haemangiosarcoma with main pulmonary artery thrombosis imitating subacute pulmonary embolism with infarction. Br J Radiol. 2004;77:623-5

Estner HL, Deisenhofer I, Luik A, Ndrepepa G, von Bary C, Zrenner B, Schmitt C: Electrical isolation of pulmonary veins in patients with atrial fibrillation: reduction of fluoroscopy exposure and procedure duration by the use of anon-fluoroscopic navigation system (NavX). Europace. 2006 Aug;8(8):583-7

Estner HL, Guenzel C, Ndrepepa G, William F, Blaumeiser D, Rupprecht B, Hessling G, Deisenhofer I, Weber MA, Wilhelm K, Schmitt C, Schoemig A: Outcome after out-of-hospital cardiac arrest in a physician-staffed emergency medical system according to the Utstein style. Am Heart J. 2007 May;153(5):792-9

Estner HL, Hessling G, Luik A, Reents T, Konietzko A, Ucer E, Wu J, Kolb C, Zrenner B, Deisenhofer I: Use of the NavX navigation system in ablation of atrial fibrillation Herzschrittmacherther. Elektrophysiol. 2007 Sep;18(3):131-9

Estner HL, Kolb C, Schmitt C, Deisenhofer I, Pflaumer A, Eicken A, Zrenner B, Hessling G: Long-term transvenous AV-sequential pacing in a failing atriopulmonary Fontan patient. Int J Cardiol. 2007 Aug 29

Estner HL, Ndrepepa G, Dong J, Deisenhofer I, Schreieck J, Schneider M, Plewan A, Karch M, Weyerbrock S, Wade D, Zrenner B, Schmitt C: Acute and long-term results of slow pathway ablation in patients with atrioventricular nodal reentrant tachycardia--an analysis of the predictive factors for arrhythmia recurrence. Pacing Clin Electrophysiol. 2005;28:102-10

Fateh-Moghadam S, Bocksch W, Ruf A, Dickfeld T, Schartl M, Pogatsa-Murray G, Hetzer R, Fleck E, Gawaz M: Changes in surface expression of platelet membrane glycoproteins and progression of heart transplant vasculopathy. Circulation 2000 22;102.890-897

Finkelstein A, Hausleiter J, Doherty T, Takizawa K, Bergman J, Liu M, Rukshin V, Fishbein M, Eigler N, Shah P, Rajavashisth T, Makkar R: Intracoronary beta-irradiation enhances balloon-injury-induced tissue factor expression in the porcine injury model. Int J Cardiovasc Intervent. 2004;6:20-7

Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, Gold HK, Virmani R: Pathological correlates of late drug-eluting stent thrombosis strut coverage as a marker of endothelialization. Circulation. 2007 May 8;115(18):2435-41

Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R: Vascular responses to drug eluting stents importance of delayed healing. Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1500-10

Finn AV, Palacios IF, Kastrati A, Gold HK: Drug-eluting stents for diabetes mellitus: a rush to judgment? J Am Coll Cardiol. 2005;45:479-83

Firschke C, Schoemig A: Mitral-valve endocarditis. New Engl J Med 345 (2001) 739

Firschke C, Zrenner B: Images in clinical medicine. Malposition of dual-chamber pacemaker lead. N Engl J Med. 2002 Feb 7;346(6).e2

Francis J, Watanabe MA, Schmidt G: Heart rate turbulence: a new predictor for risk of sudden cardiac death. Ann Noninvasive Electrocardiol. 2005;10:102-9

Frohlich G, Porner M, Wessely R: Images in cardiovascular medicine. Aortic coarctation visualized by 16-row detector multislice computed tomography. Circulation. 2005;112:e81

Gamarra F, Lingk P, Marmarova A, Edelmann M, Hautmann H, Stepp H, Baumgartner R, Huber RM: 5-Aminolevulinic acid-induced fluorescence in bronchial tumours: dependency on the patterns of tumour invasion. J Photochem Photobiol B. 2004;73:35-42

Gawaz M: Monitoring Glycoprotein IIb-IIIa Antagonists in  Patients with Coronary Artery Disease. J Lab Med. 2002 26(11/12).572-8

Gawaz M: Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium. Cardiovasc Res. 2004;61:498-511

Gawaz M, Besta F, Ylaenne J, Knorr T, Dierks H, Bohm T, Kolanus W: The NITY motif of the beta-chain cytoplasmic domain is involved in stimulated internalization of the beta3 integrin A isoform. J Cell Sci 2001 114 (2001) 1101-1113

Gawaz M, Brand K, Dickfeld T, Pogatsa-Murray G, Page S, Bogner C, Koch W, Schoemig A, Neumann F: Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. Atherosclerosis 2000;148.75-85

Gawaz M, Brand K, Dickfeld T, Pogatsa-Murray G, Page S, Bogner C, Koch W, Schoemig A, Neumann FJ: Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis. Atherosclerosis 1999, 148:75-85

Gawaz M, Konrad I, Hauser AI, Sauer S, Li Z, Wester HJ, Bengel FM, Schwaiger M, Schoemig A, Massberg S, Haubner R: Non-invasive imaging of glycoprotein VI binding to injured arterial lesions. Thromb Haemost. 2005;93:910-3

Gawaz M, Mujais SK, Schmidt B, Blumenstein M, Gurland HJ: Platelet-leukocyte aggregates during hemodialysis: effect of membrane type. Artif Organs 1999, 23:29-35

Gawaz M, Neumann FJ, Schoemig A: Evaluation of Platelet Membrane Glycoproteins in Coronary Artery Disease. 1999, Circulation, 99:e1-e11

Gawaz M, Page S, Massberg S, Nothdurfter C, Weber M, Fisher C, Ungerer M, Brand K: Transient platelet interaction induces MCP-1 production by endothelial cells via I kappa B kinase complex activation. Thromb Haemost. 2002 Aug;88(2).307-14

Gawaz M, Ruf A, Pogatsa-Murray G, Dickfeld T, Rudiger S, Taubitz W, Fischer J, Mueller I, Meier D, Patscheke H, Schoemig A: Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab. importance of internal pool of glycoprotein IIb-IIIa receptors. Thromb Haemost 2000 Jun;83(6).915-922

Gawaz M, Seyfarth M, Mueller I, Ruediger S, Pogatsa-Murray G, Wolf B, Schoemig A: Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement. Am J Cardiol 87 (2001) 332-336

Ghuran A, Reid F, La Rovere MT, Schmidt G, Bigger JT Jr, Camm AJ, Schwartz PJ, Malik M: Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The Autonomic Tone and Reflexes After Myocardial Infarction substudy) Am J Cardiol. 2002 Jan 15;89(2).184-90

Gibson CM, Schoemig A: Coronary and myocardial angiography: angiographic assessment of both epicardial and myocardial perfusion. Circulation. 2004;109:3096-105

Gick M, Jander N, Bestehorn HP, Kienzle RP, Ferenc M, Werner K, Comberg T, Peitz K, Zohlnhoefer D, Bassignana V, Buettner HJ, Neumann FJ: Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation. Circulation. 2005;112:1462-9

Gillitzer A, Peluso M, Laugwitz KL, Munch G, Massberg S, Konrad I, Gawaz M, Ungerer M: Retroviral infection and selection of culture-derived platelets allows study of the effect of transgenes on platelet physiology ex vivo and on thrombus formation in vivo. Arterioscler Thromb Vasc Biol. 2005;25:1750-5

Gorchakova O, Koch W, Mehilli J, von Beckerath N, Schwaiger M, Schoemig A, Kastrati A: PlA polymorphism of the glycoprotein IIIa and efficacy of reperfusion therapy in patients with acute myocardial infarction. Thromb Haemost. 2004;91:141-5

Gorchakova O, Koch W, von Beckerath N, Mehilli J, Schoemig A, Kastrati A: Association of a genetic variant of endothelial nitric oxide synthase with the 1 year clinical outcome after coronary stent placement. Eur Heart J. 2003;24:820-7.

Gorchakova O, von Beckerath N, Gawaz M, Mocz A, Joost A, Schoemig A, Kastrati A: Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting. Eur Heart J. 2004;25:1898-902

Grimm W, Sharkova J, Christ M, Schneider R, Schmidt G, Maisch B: Heart Rate Turbulence following Ventricular Premature Beats in Healthy Controls. Ann Noninvasive Electrocardiol. 2003;8:127-31.

Grothusen C, Umbreen S, Konrad I, Stellos K, Schulz C, Schmidt B, Kremmer E, Teebken O, Massberg S, Luchtefeld M, Schieffer B, Gawaz M: EXP3179 inhibits collagen-dependent platelet activation via glycoprotein receptor-VI independent of AT1-receptor antagonism potential impact on atherothrombosis. Arterioscler Thromb Vasc Biol. 2007 May;27(5):1184-90

Guzik P, Schmidt G: A phenomenon of heart-rate turbulence, its evaluation and prognostic value. Card Electrophysiol Rev. 2002 Sep;6(3).256-61

Guzik P, Schmidt G: Clinical significance of heart rate turbulence. Kardiol Pol. 2006 Feb;64(2):198-207. Review. Polish. Halbfass P, Plewan A, Dennig K, Kolb C, Schmitt C. TEE-guided cardioversion in patients with atrial fibrillation without previous anticoagulation. Herzschrittmacherther. Elektrophysiol. 2006 Sep;17(3):127-32. German

Hager A, Koch W, Stenzel H, Hess J, Schoeber J: Effects of movement and work load in patients with congenital central hypoventilation syndrome. Eur J Cardiovasc Prev Rehabil. 2007 Apr;14(2):294-8

Hager A, Zrenner B, Brodherr-Heberlein S, Steinbauer-Rosenthal I, Schreieck J, Hess J: Congenital and surgically acquired Wolff-Parkinson-White syndrome in patients with tricuspid atresia. J Thorac Cardiovasc Surg. 2005;130:48-53

Haissaguerre M, Shah DC, Jais P, Hocini M, Yamane T, Deisenhofer I, Chauvin M, Garrigue S, Clementy J: Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000;14;102.2463-2465

Haissaguerre M, Shah DC, Jais P, Hocini M, Yamane T, Deisenhofer I, Garrigue S, Clementy J: Mapping-guided ablation of pulmonary veins to cure atrial fibrillation. Am J Cardiol 2000;2;86.K9-K19

Hall D: The aspirin-angiotensin-converting enzyme inhibitor tradeoff. to halve and halve not. J Am Coll Cardiol 2000 Jun;35(7).1808-1812

Hallstrom AP, Stein PK, Schneider R, Hodges M, Schmidt G, Ulm K: Structural relationships between measures based on heart beat intervals: potential for improved risk assessment. IEEE Trans Biomed Eng. 2004;51:1414-20

Hallstrom AP, Stein PK, Schneider R, Hodges M, Schmidt G, Ulm K: Characteristics of heart beat intervals and prediction of death. Int J Cardiol. 2005;100:37-45

Hapke S, Gawaz M, Dehne K, Kohler J, Marshall JF, Graeff H, Schmitt M, Reuning U, Lengyel E: beta(3)A-integrin downregulates the urokinase-type plasminogen activator receptor (u-PAR) through a PEA3/ets transcriptional silencing element in the u-PAR promoter. Mol Cell Biol. 2001;21:2118-32.

Hauck RW, Lembeck RM, Emslander HP, Schoemig A: Flexible bronchoskopische Implantation von Accuflex und Strecker-Stents bei malignen Bronchialstenosen. Pneumologie 1999, 53:92-100

Hauck RW, Roemer W, Schulz C, Lembeck RM, Schoemig A, Schwaiger M: Effektivität von Metallstents - Evaluation mittels Ventilations-/Perfusions-Szintigraphie und Lungenfunktionsprüfung. Pneumologie 1999, 53: 446-543

Hauck RW, Schulz C, Schoemig A, Hoffmann RK, Panettieri RA Jr: -Thrombin mediates human bronchoconstriction by stimulation of proteinase-activated receptors. Am J Physiol, 1999, 277 (Lung Cell. Mol. Physiol.21): L22-9

Hausleiter J, Kastrati A: Is there a role for oral rapamycin in restenosis prevention after bare-metalstent implantation?. Nat Clin Pract Cardiovasc Med. 2006 Sep;3(9):476-7

Hausleiter J, Kastrati A, Mehilli J, Dotzer F, Schuehlen H, Dirschinger J, Schoemig A: Comparative analysis of stent placement versus balloon angioplasty in small coronary arteries with long narrowings (the Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries [ISAR-SMART] Trial). Am J Cardiol. 2002 Jan 1;89(1).58-60

Hausleiter J, Kastrati A, Mehilli J, Schuehlen H, Pache J, Dotzer F, Dirschinger J, Schoemig A: Predictive factors for early cardiac events and angiographic restenosis after coronary stent placement in small coronary arteries. J Am Coll Cardiol. 2002 Sep 4;40(5).882-9

Hausleiter J, Kastrati A, Mehilli J, Schuehlen H, Pache J, Dotzer F, Glatthor C, Siebert S, Dirschinger J, Schoemig A: A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries. J Intern Med. 2004;256:388-97

Hausleiter J, Kastrati A, Mehilli J, Schuehlen H, Pache JJ, Dirschinger J, Schricke U, Schwaiger M, Markward C, Schoemig A: Impact of acute myocardial infarct location on myocardial salvage after stenting or thrombolysis (results from the STOPAMI 1 and 2 trials): Stent versus Thrombolysis for Occluded coronary arteries in Patients with Acute Myocardial Infarction. Am J Cardiol. 2003;91:341-3.

Hausleiter J, Kastrati A, Mehilli J, Vogeser M, Zohlnhoefer D, Schuehlen H, Goos C, Pache J, Dotzer F, Pogatsa-Murray G, Dirschinger J, Heemann U, Schoemig A: Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial. Circulation. 2004;110:790-5

Hausleiter J, Kastrati A, Wessely R, Dibra A, Mehilli J, Schratzenstaller T, Graf I, Renke-Gluszko M, Behnisch B, Dirschinger J, Wintermantel E, Schoemig A: Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer free, on-site stent coating. Eur Heart J. 2005;26:1475-81

Hausleiter J, Li AN, Abbey CK, Makkar R, Whiting JS, Eigler N: Validation of the localization of the target tissue for intracoronary brachytherapy. Z Kardiol. 2002 91(Suppl. 3), 10-6.

Hausleiter J, Meyer T, Hadamitzky M, Huber E, Zankl M, Martinoff S,Kastrati A, Schoemig A: Radiation dose estimates from cardiac multislice computed tomography in dailypractice: impact of different scanning protocols on effective dose estimates. Circulation. 2006 Mar 14;113(10):1305-10

Hausleiter J, Meyer T, Hadamitzky M, Kastrati A, Martinoff S, Schoemig A: Prevalence of noncalcified coronary plaques by 64-slice computed tomography in patients with an intermediate risk for significant coronary artery disease. J Am Coll Cardiol. 2006 Jul 18;48(2):312-8

Hausleiter J, Meyer T, Hadamitzky M, Zankl M, Gerein P, Doerrler K, Kastrati A, Martinoff S, Schoemig A: Non-invasive coronary computed tomographic angiography for patients with suspected coronary artery disease the Coronary Angiography by Computed Tomography with the Use of a Submillimeter resolution (CACTUS) trial. Eur Heart J. 2007 Dec;28(24):3034-41

Hausleiter J, Sebastian M, Li AN, Abbey CK, Honda H, Makkar R, Whiting JS, Eigler N: A porcine coronary stent model of increased neointima formation in the left anterior descending coronary arteryZ Kardiol. 2002 Aug;91(8).614-9

Hautmann H, Schneider A, Pinkau T, Peltz F, Feussner H: Electromagnetic catheter navigation during bronchoscopy: validation of a novel method by conventional fluoroscopy. Chest. 2005;128:382-7

Herrmann R, Schmidmaier G, Maerkl B, Resch A, Haehnel I, Stemberger A, Alt E: Antithrombotic coating of stents using a biodegradable drug delivery technology. Thromb Haemostasis 1999; 82:51-7

Hjort PF, Sandset PM, Abildgaard U, Rao LV, Mast A, Ott I, Bajaj SP: Tissue factor pathway inhibitor revisited. J Thromb Haemost. 2004;2:2241-9

Hofmann B, Ladwig KH, Schapperer J, Deisenhofer I, Marten-Mittag B, Danner R, Schmitt C: Psycho-neurogene Faktoren bei der Genese lebensbedrohlicher Arrhythmien; Nervenarzt, 1999, 70:830-5

Hofmann M, Bauer R, Handrock R, Weidinger G, Goedel-Meinen L: Prognostic value of the QRS duration in patients with heart failure: a subgroup analysis from 24 centers of Val-HeFT. J Card Fail. 2005;11:523-8

Hofmann M, Goedel-Meinen L, Leipert H, Schad H, Heimisch W, Mendler N, Schoemig A: Spectrotemporal Mapping of High Resolution ECGs in Experimental Myocardial Infarction: Comparison with Time-Domain Analysis and Epicardial Electrograms. PACE 1999; 22:1333-43

Holzapfel K, von Beckerath N, Rummeny EJ, Gaa J: Rezidivierendes Nasenbluten, Atemnot und auffallige Befunde an Lunge und Leber. Radiologe. 2006 Oct 7; German

Holzapfel K, von Beckerath N, Rummeny EJ, Gaa J: conspicuous findings in the lung and liver. Radiologe. 2007 Aug;47(8):716-20. German

Hoppmann P, Koch W, Schoemig A, Kastrati A: The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions. Eur Heart J. 2004;25:335-41

Horcher J, Blasini R, Martinoff S, Schwaiger M, Schoemig A, Firschke C: Myocardial Perfusion in Acute Coronary Syndrome. 1999, Circulation, 99:e15

Hsu LF, Jais P, Keane D, Wharton JM, Deisenhofer I, Hocini M, Shah DC, Sanders P, Scavee C, Weerasooriya R, Clementy J, Haissaguerre M: Atrial fibrillation originating from persistent left superior vena cava. Circulation. 2004;109:828-32

Huber W, Schipek C, Ilgmann K, Page M, Hennig M, Wacker A, Schweigart U, Lutilsky L, Valina C, Seyfarth M, Schoemig A, Classen M: Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency. Am J Cardiol. 2003;91:1157-62.

Ibrahim T, Buelow HP, Hackl T, Hoernke M, Nekolla SG, Breuer M, Schoemig A, Schwaiger M: Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction. J Am Coll Cardiol. 2007 Jan 16;49(2):208-16

Ibrahim T, Dennig K, Schwaiger M, Schoemig A: Images in cardiovascular medicine. Assessment of double chamber right ventricle by magnetic resonance imaging. Circulation. 2002 Jun 4;105(22).2692-3

Ibrahim T, Nekolla SG, Hornke M, Bulow HP, Dirschinger J, Schoemig A, Schwaiger M: Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: comparison with single-photon emission tomography using Tc99m-sestamibi. J Am Coll Cardiol. 2005;45:544-52

Ibrahim T, Nekolla SG, Schreiber K, Odaka K, Volz S, Mehilli J, Guthlin M, Delius W, Schwaiger M: Assessment of coronary flow reserve. comparison between contrast-enhanced magnetic resonance imaging and positron emission tomography. J Am Coll Cardiol. 2002 Mar 6;39(5).864-70

Ibrahim T, Schwaiger M: Diagnosis of apical hypertrophic cardiomyopathy using magnetic resonance imaging. Heart 2000 Jan;83(1).E1

Ibrahim T, Schwaiger M, Schoemig A: Images in cardiovascular medicine. Assessment of isolated right ventricular myocardial infarction by magnetic resonance imaging. Circulation. 2006 Feb 14;113(6):e78-9

Iijima R, Mehilli J, Schoemig A, Kastrati A: Clinical evidence on polymer-based sirolimus and paclitaxel eluting stents. Minerva Cardioangiol. 2006 Oct;54(5):539-55

Iijima R, Ndrepepa G, Mehilli J, Bruskina O, Schulz S, Schoemig A, Kastrati A: Relationship between platelet count and 30-day clinical outcomes after percutaneous coronary interventions. Pooled analysis of four ISAR trials. Thromb Haemost. 2007 Oct;98(4):852-7

Iijima R, Ndrepepa G, Mehilli J, Markwardt C, Bruskina O, Pache J, Ibrahim M, Schoemig A, Kastrati A: Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era. Am Heart J. 2007 Oct;154(4):688-93

Iijima R, Ndrepepa G, Mehilli J, Neumann FJ, Schulz S, ten Berg J, Bruskina O, Dotzer F, Dirschinger J, Berger PB, Schoemig A, Kastrati A: Troponin level and efficacy of abciximab in patients with acute coronary syndromes undergoing early intervention after clopidogrel pretreatment. Clin Res Cardiol. 2007 Nov 28

Jais P, Hocini M, Gillet T, Shah DC, Haissaguerre M, Yamane T, Deisenhofer I, Garrigue S, Le Metayer P, Roudaut R, Clementy J: Effectiveness of irrigated tip catheter ablation of common atrial flutter. Am J Cardiol 15 (2001) 433-5

Jais P, Hocini M, Macle L, Choi KJ, Deisenhofer I, Weerasooriya R, Shah DC, Garrigue S, Raybaud F, Scavee C, Le Metayer P, Clementy J, Haissaguerre M: Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation. 2002 Nov 5;106(19).2479-85

Jaschke B, Michaelis C, Milz S, Vogeser M, Mund T, Hengst L, Kastrati A, Schoemig A, Wessely R: Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform. Cardiovasc Res. 2005;68:483-92

Jaschke B, Milz S, Vogeser M, Michaelis C, Vorpahl M, Schoemig A, Kastrati A, Wessely R: Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury. Faseb J. 2004;18:1285-7

Joner M, Farb A, Cheng Q, Finn AV, Acampado E, Burke AP, Skorija K, Creighton W, Kolodgie FD, Gold HK, Virmani R: Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-beta and MCP-1. Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):182-9

Junker-Neff A, Eberle R, T VA, Mehilli J, Hollweck R: Is there an association between the morning peak in the onset of acute myocardial infarction and the sleep apnea syndrome?. Dtsch Med Wochenschr. 2005;130:2818-22

Junt T, Moseman EA, Iannacone M, Massberg S, Lang PA, Boes M, Fink K, Henrickson SE, Shayakhmetov DM, Di Paolo NC, van Rooijen N, Mempel TR, Whelan SP, von Andrian UH: Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells. Nature. 2007 Nov 1;450(7166):110-4

Junt T, Schulze H, Chen Z, Massberg S, Goerge T, Krueger A, Wagner DD, Graf T, Italiano JE Jr, Shivdasani RA, von Andrian UH: Dynamic visualization of thrombopoiesis within bone marrow. Science. 2007 Sep 21;317(5845):1767-70

Kalyanasundaram A, Berger P, Kastrati A: Effects of glycoprotein IIb/IIIa blockers. Heart. 2007 Oct;93(10):1293

Kandzari DE, Berger PB, Kastrati A, Steinhubl SR, Mehilli J, Dotzer F, ten Berg JM, Neumann FJ, Bollwein H, Dirschinger J, Schoemig A: Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization. J Am Coll Cardiol. 2004;44:2133-6

Kandzari DE, Hasselblad V, Tcheng JE, Stone GW, Califf RM, Kastrati A, Neumann FJ, Brener SJ, Montalescot G, Kong DF, Harrington RA: Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials. Am Heart J. 2004;147:457-62

Kannemeier C, Shibamiya A, Nakazawa F, Trusheim H, Ruppert C, Markart P, Song Y, Tzima E, Kennerknecht E, Niepmann M, von Bruehl ML, Sedding D, Massberg S, Guenther A, Engelmann B, Preissner KT: Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation. Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6388-93

Kantelhardt JW, Bauer A, Schumann AY, Barthel P, Schneider R, Malik M, Schmidt G: Phase-rectified signal averaging for the detection of quasi-periodicities and the prediction of cardiovascular risk. Chaos. 2007 Mar;17(1):015112

Karch M, Schreieck J, Zrenner B: Gegenwärtiger Stand der Vorhofflimmerablation. Herzschr Elektrophys. 2002 13.178-85

Karch MR, Ndrepepa G, Schneider MA, Weber S, Schreieck J, Schmitt C: Single chamber atrial fibrillation involving only the left atrium: implications for maintenance and radiofrequency ablation therapy. Pacing Clin Electrophysiol. 2003;26:883-91.

Karch MR, Ndrepepa G, Zrenner B, Saur C, Schneider MA, Schoemig A, Schmitt CS: Simultaneous multisite endocardial mapping of sustained and non-sustained atrial fibrillation in humans. J Invasive Cardiol. 2003;15:257-62.

Karch MR, Schmieder S, Ndrepepa G, Schneider MAE, Zrenner B, Schmitt C: Internal atrial defibrillation during electrophysiological studies and focal atrial fibrillation ablation procedures. PACE 24 (2001) 1464-1469

Karch MR, Zrenner B, Deisenhofer I, Schreieck J, Ndrepepa G, Dong J, Lamprecht K, Barthel P, Luciani E, Schoemig A, Schmitt C: Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation. 2005;111:2875-80

Kastrati A: Drug-eluting stents for secondary prevention of restenosis. Catheter Cardiovasc Interv. 2004;63:265-6

Kastrati A, Dibra A, Eberle S, Mehilli J, Suarez de Lezo J, Goy JJ, Ulm K, Schoemig A: Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. Jama. 2005;294:819-25

Kastrati A, Dibra A, Mehilli J, Mayer S, Pinieck S, Pache J, Dirschinger J, Schoemig A: Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation. 2006 May 16;113(19):2293-300

Kastrati A, Dibra A, Spaulding C, Laarman GJ, Menichelli M, Valgimigli M, Di Lorenzo E, Kaiser C, Tierala I, Mehilli J, Seyfarth M, Varenne O, Dirksen MT, Percoco G, Varricchio A, Pittl U, Syvaenne M, Suttorp MJ, Violini R, Schoemig A: Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J. 2007 Nov;28(22):2706-13

Kastrati A, Dirschinger J, Schoemig A: Genetic risk factors and restenosis after percutaneous coronary interventions. Herz 2000;25.34-46

Kastrati A, Elezi S, Dirschinger J, Hadamitzky M, Neumann FJ, Schoemig A: Influence of lesion length on restenosis after coronary stent placement. Am J Cardiol, 1999, 83:1617-22

Kastrati A, Elezi S, Schoemig A: A friend in need is a friend indeed: the case of drug-eluting stents, diabetes and small vessel size. Rev Esp Cardiol. 2006 Oct;59(10):991-3. Spanish

Kastrati A, Hall D, Schoemig A: Long-term outcome after coronary stenting. Curr Control Trials Cardiovasc Med 2000; 48-54

Kastrati A, Koch W, Berger PB, Mehilli J, Stephenson K, Neumann FJ, von Beckerath N, Boettiger C, Duff GW, Schoemig A: Protective role against restenosis from an interleukin-1 receptor antagonist gene orphism in patients treated with coronary stenting. J Am Coll Cardiol 2000; 36. 2168-2173

Kastrati A, Mehilli J, Dirschinger J, Dotzer F, Schuehlen H, Neumann FJ, Fleckenstein M, Pfafferott C, Seyfarth M, Schoemig A: Intracoronary stenting and angiographic results . strut thickness effect on restenosis outcome (ISAR- STEREO) trial. Circulation 103 (2001) 2816-21

Kastrati A, Mehilli J, Dirschinger J, Pache J, Ulm K, Schuehlen H, Seyfarth M, Schmitt C, Blasini R, Neumann FJ, Schoemig A: Restenosis after coronary placement of various stent types. Am J Cardiol 87 (2001) 34-39

Kastrati A, Mehilli J, Dirschinger J, Schricke U, Neverve J, Pache J, Martinoff S, Neumann FJ, Nekolla S, Blasini R, Seyfarth M, Schwaiger M, Schoemig A: Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction. a randomised trial. Lancet. 2002 Mar 16;359(9310).920-5

Kastrati A, Mehilli J, Nekolla S, Bollwein H, Martinoff S, Pache J, Schuehlen H, Seyfarth M, Gawaz M, Neumann FJ, Dirschinger J, Schwaiger M, Schoemig A: A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy. J Am Coll Cardiol. 2004;43:734-41

Kastrati A, Mehilli J, Neumann FJ, Dotzer F, ten Berg J, Bollwein H, Graf I, Ibrahim M, Pache J, Seyfarth M, Schuhlen H, Dirschinger J, Berger PB, Schoemig A: Intracoronary Stenting and Antithrombotic: Regimen Rapid Early Action forCoronary Treatment 2 (ISAR-REACT 2) Trial Investigators. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2randomized trial. Jama. 2006 Apr 5;295(13):1531-8

Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabaté M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schoemig A: Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med. 2007 Mar 8;356(10):1030-9

Kastrati A, Mehilli J, Schlotterbeck K, Dotzer F, Dirschinger J, Schmitt C, Nekolla SG, Seyfarth M, Martinoff S, Markwardt C, Clermont G, Gerbig HW, Leiss J, Schwaiger M, Schoemig A: Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial. Jama. 2004;291:947-54

Kastrati A, Mehilli J, Schuehlen H, Dirschinger J, Dotzer F, ten Berg JM, Neumann FJ, Bollwein H, Volmer C, Gawaz M, Berger PB, Schoemig A: A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel. N Engl J Med. 2004;350:232-8

Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, Schuehlen H, Schmitt C, Dirschinger J, Schoemig A: Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. Jama. 2005;293:165-71

Kastrati A, Pache J, Dirschinger J, Neumann FJ, Walter H, Schmitt C, Schoemig A: Primary intracoronary stenting in acute myocardial infarction. long-term clinical and angiographic follow-up and risk factor analysis. Am Heart J 2000; 139. 208-216

Kastrati A, Schoemig A: Good medicines for bad genes. Eur Heart J 22 (2001) 523-5

Kastrati A, Schoemig A: Drug-eluting stents is their future as bright as their past? J Am Coll Cardiol. 2007 Jul 10;50(2):146-8

Kastrati A, Schoemig A, Dirschinger J, Mehilli J, Dotzer F, von Welser N, Neumann FJ: A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease. Circulation 2000 21; 102. 2593-2598

Kastrati A, Schoemig A, Dirschinger J, Mehilli J, von Welser N, Pache J, Schuehlen H, Schilling T, Schmitt C, Neumann FJ: Increased risk of restenosis after placement of gold-coated stents. results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation 2000; 101. 2478-2483

Kastrati A, Schoemig A, Elezi S, Dirschinger J, Mehilli J, Schuehlen H, Blasini R, Neumann FJ: Prognostic Value of the Modified American College of Cardiology/American Heart Association Stenosis, Morphology Classification for Long-Term Angiographic and Clinical Outcome after Coronary Stent Placement. Circulation, 1999, 100:1285-90

Kastrati A, Schoemig A, Schoemig E: Are we making efficient use of clopidogrel?. Eur Heart J. 2004;25:454-6

Kastrati A, Schoemig A, Seyfarth M, Koch W, Elezi S, Boettiger C, Mehilli J, Schoemig K, von Beckerath N: PLA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement. Circulation. 1999;99:1005-10

Kastrati A, Schuehlen H, Schoemig A: Stenting for small coronary vessels. a contestable winner. J Am Coll Cardiol 38 (2001)1604-7

Kastrati A, von Beckerath N, Joost A, Pogatsa-Murray G, Gorchakova O, Schoemig A: Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy. Circulation. 2004;110:1916-9

Koch W, Boettiger C, Mehilli J, von Beckerath N, Neumann FJ, Schoemig A, Kastrati A: Association of a CD18 gene orphism with a reduced risk of restenosis after coronary stenting.  Am J Cardiol 88 (2001) 1120-4

Koch W, Ehrenhaft A, Griesser K, Pfeufer A, Mueller J, Schoemig A, Kastrati A: TaqMan Systems for Genotyping of Disease-Related orphisms Present in the Gene Encoding Apolipoprotein E. Clin Chem Lab Med 2002; 40(11).1123-1131

Koch W, Hoppmann P, Michou E, Jung V, Pfeufer A, Mueller JC, Gieger C, Wichmann HE, Meitinger T, Schoemig A, Kastrati A: Association of variants in the BAT1-NFKBIL1-LTA genomic region with protection against myocardial infarction in Europeans. Hum Mol Genet. 2007 Aug 1;16(15):1821-7

Koch W, Hoppmann P, Michou E, Jung V, Pfeufer A, Muller J, Meitinger T, Schoemig A, Kastrati A: TaqMan assays for genotyping of single nucleotide polymorphisms present at a disease susceptibility locus on chromosome 6. Clin Chem Lab Med. 2005;43:167-72

Koch W, Hoppmann P, Mueller JC, Schoemig A, Kastrati A: Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heartdisease. Arterioscler Thromb Vasc Biol. 2006 May;26(5):1114-9

Koch W, Hoppmann P, Mueller JC, Schoemig A, Kastrati A: No association of polymorphisms in the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a large central European population. Genet Med. 2007 Feb;9(2):123-9. Erratum in Genet Med. 2007 Mar;9(3):187

Koch W, Hoppmann P, Pfeufer A, Mueller JC, Schoemig A, Kastrati A: No replication of association between estrogen receptor alpha gene polymorphisms and susceptibility to myocardial infarction in a large sample of patients of European descent. Circulation. 2005;112:2138-42

Koch W, Hoppmann P, Pfeufer A, Schoemig A, Kastrati A: Toll-like receptor 4 gene polymorphisms and myocardial infarction: no association in a Caucasian population. Eur Heart J. 2006 Nov;27(21):2524-9

Koch W, Hoppmann P, Schoemig A, Kastrati A: Apolipoprotein E gene epsilon2/epsilon3/epsilon4 polymorphism and myocardial infarction Case-control study in a large population sample. Int J Cardiol. 2007 Apr 10

Koch W, Jung V, von Beckerath N, Schoemig A, Kastrati A: Peroxisome proliferator-activated receptor gamma gene polymorphisms and restenosis in diabetic patients after stenting in coronary arteries. Diabetologia. 2004;47:1126-7

Koch W, Kastrati A, Boettiger C, Mehilli J, von Beckerath N, Schoemig A: Interleukin-10 and tumor necrosis factor gene orphisms and risk of coronary artery disease and myocardial infarction Atherosclerosis 159 (2001) 137-44

Koch W, Kastrati A, Mehilli J, Boettiger C, von Beckerath N, Schoemig A: Insertion/deletion orphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement. Circulation 2000; 102. 197-202

Koch W, Kastrati A, Mehilli J, von Beckerath N, Schoemig A: CD14 gene -159C/T orphism is not associated with coronary artery disease and myocardial infarction. Am Heart J. 2002 Jun;143(6).971-6

Koch W, Latz W, Eichinger M, Ganser C, Schoemig A, Kastrati A: Genotyping of the angiotensin I-converting enzyme gene insertion/deletion polymorphism by the TaqMan method. Clin Chem. 2005;51:1547-9

Koch W, Latz W, Eichinger M, Roguin A, Levy AP, Schoemig A, Kastrati A: Genotyping of the common haptoglobin Hp 1/2 orphism based on PCR. Clin Chem. 2002 Sep;48(9).1377-82

Koch W, Mehilli J, Pfeufer A, Schoemig A, Kastrati A: Apolipoprotein E gene polymorphisms and thrombosis and restenosis after coronary artery stenting. J Lipid Res. 2004;45:2221-6

Koch W, Mehilli J, von Beckerath N, Boettiger C, Schoemig A, Kastrati A: Angiotensin I-converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene. J Am Coll Cardiol. 2003;41:1957-61.

Kolb C: Ausweis für Defibrillatorpatienten. Basisinformationen zum ICD.  MMW Fortschr Med 2001;143(3).42-44

Kolb C: Strategies for the avoidance and treatment of complications during pacemaker implantation. Herzschrittmacherther Elektrophysiol. 2007 Dec;18(4):234-42

Kolb C, Aratma S, Zrenner B, Schmitt C: Preventricular far-field sensing in the atrial channel of dual chamber pacemakers--an occasional cause of inappropriate mode switch. J Interv Card Electrophysiol. 2004;10:231-5

Kolb C, Deisenhofer I, Schmieder S, Barthel P, Zrenner B, Karch MR, Schmitt C: Long-term follow-up of patients supplied with single-chamber or dual-chambercardioverter defibrillators. Pacing Clin Electrophysiol. 2006 Sep;29(9):946-52

Kolb C, Deisenhofer I, Weyerbrock S, Schmieder S, Plewan A, Zrenner B, Schmitt C: Incidence of antitachycardia therapy suspension due to magnet reversion in implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2004;27:221-3

Kolb C, Eicken A, Zrenner B, Schmitt C: Cardiac pacing in a patient with diaphragm pacing for congenital central hypoventilation syndrome (Ondine's curse). J Cardiovasc Electrophysiol. 2006 Jul;17(7):789-91

Kolb C, Halbfass P, Zrenner B, Schmitt C: Paradoxical atrial undersensing due to inappropriate atrial noise reversion of atrial fibrillation in dual-chamber pacemakers. J Cardiovasc Electrophysiol. 2005;16:696-700

Kolb C, Lehmann G, Schreieck J, Ndrepepa G, Schmitt C: Storms of ventricular tachyarrhythmias associated with primary hyperparathyroidism in a patient with dilated cardiomyopathy. Int J Cardiol. 2003;87:115-6.

Kolb C, Luik A, Hessling G, Zrenner B: Magnetic catheter navigation system interference with a dual-chamber pacemaker. J Cardiovasc Electrophysiol. 2007 Aug;18(8):892-3

Kolb C, Markwardt C, Zrenner B, Schmitt C: Pacemaker Auto-Interference by Thoracic Impedance Measurement for the Rate Response Function. Pacing Clin Electrophysiol. 2005;28:1360-2

Kolb C, Nuernberger S, Ndrepepa G, Zrenner B, Schoemig A, Schmitt C: Modes of initiation of paroxysmal atrial fibrillation from analysis of spontaneously occurring episodes using a 12-lead Holter monitoring system. Am J Cardiol 88 (2001) 853-857

Kolb C, Schmieder S, Lehmann G, Zrenner B, Karch MR, Plewan A, Schmitt C: Do airport metal detectors interfere with implantable pacemakers or cardioverter-defibrillators? J Am Coll Cardiol. 2003;41:2054-9.

Kolb C, Schmieder S, Schmitt C: nappropriate shock delivery due to interference between a washing machine and an implantable cardioverter defibrillator. J Interv Card Electrophysiol. 2002 Dec;7(3).255-6

Kolb C, Schmitt C: Mögliche Störungen von Herzschrittmachern und implantierten Defibrillatoren. Kardiologie up2date 2006;2:119-26

Kolb C, Wille B, Maurer D, Schuchert A, Weber R, Schibgilla V, Klein N, Hummer A, Schmitt C, Zrenner B, FFS-Test Study Group: Management of far-field R wave sensing for the avoidance of inappropriate modes witch in dual chamber pacemakers: results of the FFS-test study. J Cardiovasc Electrophysiol. 2006 Sep;17(9):992-7

Kolb C, Zrenner B, Schmitt C: Incidence of electromagnetic interference in implantable cardioverter defibrillators.  PACE 24 (2001) 465-468

Kolb C, Zrenner B, Schmitt C: Successful pacemaker lead implantation via the subclavian vein despite of high degree stenosis of the vein. Pacing Clin Electrophysiol. 2005;28:1135-7

Kolb C, Zrenner B, Schmitt C: Near-fatal incident on routine induction of ventricular fibrillation at there placement of an implantable cardioverter defibrillator. Int J Cardiol. 2006 Oct 10;112(3):e74-5

Kolling K, Ndrepepa G, Koch W, Braun S, Mehilli J, Schoemig A, Kastrati A: Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease. Am J Cardiol. 2004;93:1201-6

Kuhn A, Schreiber C, Hausleiter J, Vogt M: Giant right atrial aneurysm in a symptomatic adult - a rare congenitalmalformation. Eur Heart J. 2006 Oct;27(20):2375

Ladwig KH , Muhlberger N, Walter H, Schumacher K, Holle R, Zitzmann-Roth , Popp KE, Schoemig A: Gender differences in emotional disability and negative health perception in cardiac patients 6 months after stent implantation. J Psychosom Res 2000; 48. 501-508

Ladwig KH, Deisenhofer I, Simon H, Schmitt C, Baumert JJ: Characteristics associated with low treatment satisfaction in patients with implanted cardioverter defibrillators: results from the LICAD study. Pacing Clin Electrophysiol. 2005;28:506-13

Ladwig KH, Deisenhofer I, Simon H, Schmitt C, Baumert JJ: Characteristics associated with low treatment satisfaction in patients with implanted cardioverter defibrillators: results from the LICAD study. Pacing Clin Electrophysiol. 2005 Jun;28(6):506-13

Ladwig KH, Lehmann G, Marten-Mittag B, Simon H, Alt E: Treatment satisfaction of internal versus external cardioversion in patients with chronic atrial fibrillation--a randomized, prospective, 28-day follow-up study. Clin Cardiol. 2003;26:10-6.

Ladwig KH, Marten-Mittag B, Deisenhofer I, Hofmann B, Schapperer J, Weyerbrock S, Erazo N, Schmitt C: Psychophysiological correlates of peritraumatic dissociative responses in survivors of life-threatening cardiac events. Psychopathology. 2002 Jul-Aug;35(4).241-8

Ladwig KH, Marten-Mittag B, Deisenhofer I, Hofmann B, Schapperer J, Weyerbrock S, Schmitt C: Exaggerated electrodermal startle responses after intracardiac shock discharges in patients with implanted cardioverter defibrillators. Psychosom Med. 2003;65:222-8.

Ladwig KH, Wirsching C, A VH, Danner R, Baumert J, Schmitt C: Anxiety and anxiety management in patients with implanted cardioverter-defibrillators. Dtsch Med Wochenschr. 2004;129:2311-5

Lammers A, Kaemmerer H, Hollweck R, Schneider R, Barthel P, Braun S, Wacker A, Brodherr-Heberlein S, Hauser M, Eicken A, Schmidt G, Hess J: Impaired cardiac autonomic nervous activity predicts sudden cardiac death in patients with operated and unoperated congenital cardiac disease. J Thorac Cardiovasc Surg. 2006 Sep;132(3):647-55

Lang SM, Ebelt K, Hautmann H, Stratakis DF, Huber RM: Detection of cancerous endobronchial lesions by autofluorescence bronchoscopy combined with mutation analysis of p53. Eur J Med Res. 2005;10:273-7

Langer H, May AE, Daub K, Heinzmann U, Lang P, Schumm M, Vestweber D, Massberg S, Schonberger T, Pfisterer I, Hatzopoulos AK, Gawaz M: Adherent platelets recruit and induce differentiation of murine embryonicendothelial progenitor cells to mature endothelial cells in vitro. Circ Res. 2006 Feb 3;98(2):e2-10

Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, Woodard S, Lin LZ, Cai CL, Lu MM, Reth M, Platoshyn O, Yuan JX, Evans S, Chien KR: Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature. 2005;433:647-53

Laugwitz KL, Moretti A, Weig HJ, Gillitzer A, Pinkernell K, Ott T, Pragst I, Staedele C, Seyfarth M, Schoemig A, Ungerer M: Blocking caspase-activated apoptosis improves contractility in failing myocardium.  Hum Gene Ther 12 (2001) 2051-2063

Laugwitz KL, Ungerer M, Schoeneberg T, Weig HJ, Kronsbein K, Moretti A, Hoffmann K, Seyfarth M, Schultz G, Schoemig A: Adenoviral Gene Transfer of the Human V2 Vasopressin Receptor Improves Contractile Force of Rat Cardiomyocytes. Circulation, 1999, 99:925-33

Laugwitz KL, Weig HJ, Moretti A, Hoffmann E, Uebelacker P, Pragst I, Rosport K, Schoemig A, Ungerer M: Gene transfer of heterologous G-protein coupled receptors to cardiomyocytes. differential effects on contractility.  Circ Res 88 (2001) 688-695

Lazar A, Zimmermann T, Koch W, Grundemann D, Schoemig A, Kastrati A, Schoemig E: Lower prevalence of the OCT2 Ser270 allele in patients with essential hypertension. Clin Exp Hypertens. 2006 Oct;28(7):645-53

Lehmann G, Deisenhofer I, Ndrepepa G, Schmitt C: ECG changes in a 25-year-old woman with hypocalcemia due to hypoparathyroidism. Chest 2000; 118. 260-262

Lehmann G, Deisenhofer I, Zrenner B, Schmitt C: Recurrent Symptomatic Bilateral Bundle Branch Block in a 74-Year-Old Patient with a Prosthetic Aortic Valve. Int J Cardiol, 1999; 71

Lehmann G, Horcher J, Dennig K, Plewan A, Ulm K, Alt E: Atrial mechanical performance after internal and external cardioversion of atrial fibrillation. an echocardiographic study. Chest. 2002 Jan;121(1).13-8

Lehmann G, Kolb C: Questionable dysfunction of a dual-Chamber pacemaker in a 17-year-old female; Differential diagnoses of missing ventricular beats. Int J Cardiol. 2004;97:567-569

Lehmann G, Ndrepepa G, Schmitt C: Digitoxin Intoxication in a 79-year-old patient. a description of a case and review of the literature. International Journal of Cardiology 2000; 75. 109-113

Lehmann G, Schmitt C, Kehl V, Schmieder S, Schoemig A: Electrocardiographic algorithm for assignment of occluded vessel in acute myocardial infarction. Int J Cardiol. 2003;89:79-85.

Lersch C, Eckel F, Sader R, Paschalidis M, Zeilhofer F, Schulte-Frohlinde, Theiss W: Initial Experience with Healthport miniMAX(r) and other Peripheral Arm Ports in Patients with Advanced Gastrointestinal Malignancy. Oncology, 1999, 57:269-75

Lersch C, Paschalidis M, Theiss W: Tiefe Venenthrombosen durch zentralvenöse Katheter; Vasa-J Vascular Dis1999; 28:71-8

Louvard Y, Thomas M, Dzavik V, Hildick-Smith D, Galassi AR, Pan M, Burzotta F, Zelizko M, Dudek D, Ludman P, Sheiban I, Lassen JF, Darremont O, Kastrati A, Ludwig J, Iakovou I, Brunel P, Lansky A, Meerkin D, Legrand V, Medina A, Lefèvre T: Classification of coronary artery bifurcation lesions and treatments. Time for a consensus! Catheter Cardiovasc Interv. 2007 Nov 5

Luik A, Deisenhofer I, Estner H, Ndrepepa G, Pflaumer A, Zrenner B, Schmitt C: Atresia of the coronary sinus in patients with supraventricular tachycardia. Pacing Clin Electrophysiol. 2006 Feb;29(2):171-4

Lüscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, Virmani R: Drug-eluting stent and coronary thrombosis biological mechanisms and clinical implications. Circulation. 2007 Feb 27;115(8):1051-8

Majahalme SK, Baruch L, Aknay N, Goedel-Meinen L, Hofmann M, Hester A, Prescott MF, Feliciano N: Comparison of treatment benefit and outcome in women versus men with chronic heart failure (from the Valsartan Heart Failure Trial). Am J Cardiol. 2005;95:529-32

Makikallio TH, Barthel P, Schneider R, Bauer A, Tapanainen JM, Tulppo MP, Perkiomaki JS, Schmidt G, Huikuri HV: Frequency of sudden cardiac death among acute myocardial infarction survivors with optimized medical and revascularization therapy. Am J Cardiol. 2006 Feb 15;97(4):480-4. Epub 2005 Dec 22

Makikallio TH, Barthel P, Schneider R, Bauer A, Tapanainen JM, Tulppo MP, Schmidt G, Huikuri HV: Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. Eur Heart J. 2005;26:762-9

Makkar R, Whiting JS, Li AN, Honda H, Fishbein MC, Knapp FF, Hausleiter J, Litvack F, Eigler NL: Effects of ss(-)-emitting (188)Re balloon in stented porcine coronary arteries. An angiographic, intravascular ultrasound, and histomorphometric study. Circulation 2000; 19;102 (25). 3117-3123

Malik M, Wichterle D, Schmidt G: Heart-rate turbulence. G Ital Cardiol 2000 Vol 29, Suppl 5. 65-69

Marten K, Fend F, Hautmann H, Kremer M, Rummeny EJ, Engelke C: Case report: Fatal acute exacerbation of usual interstitial pneumonia in ulcerative colitis. Br J Radiol. 2005;78:762-6

Martin JB, Pache JC, Treggiari-Venzi M, Murphy KJ, Gailloud P, Puget E, Pizzolato G, Sugiu K, Guimaraens L, Theron J, Rufenacht DA: Role of the distal balloon protection technique in the prevention of cerebral embolic events during carotid stent placement. Stroke. 2001;32:479-84.

Massberg S, Brand K, Gruner S, Page S, Mueller E, Mueller I, Bergmeier W, Richter T, Lorenz M, Konrad I, Nieswandt B, Gawaz M: A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002 Oct 7;196(7).887-96

Massberg S, Enders G, de Melo Matos F, Leiderer R, Domschke TL, Eisenmenger S, Messmer K, Krombach F: Fibrinogen deposition at the post-ischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo. Blood, 1999 94:3829-38

Massberg S, Gawaz M, Gruner S, Schulte V, Konrad I, Zohlnhoefer D, Heinzmann U, Nieswandt B: A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med. 2003;197:41-9.

Massberg S, Gruner S, Konrad I, Garcia Arguinzonis MI, Eigenthaler M, Hemler K, Kersting J, Schulz C, Muller I, Besta F, Nieswandt B, Heinzmann U, Walter U, Gawaz M: Enhanced in vivo platelet adhesion in vasodilator-stimulated phosphoprotein (VASP)-deficient mice. Blood. 2004;103:136-42

Massberg S, Konrad I, Bultmann A, Schulz C, Munch G, Peluso M, Lorenz M, Schneider S, Besta F, Muller I, Hu B, Langer H, Kremmer E, Rudelius M, Heinzmann U, Ungerer M, Gawaz M: Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. Faseb J. 2004;18:397-9

Massberg S, Konrad I, Schurzinger K, Lorenz M, Schneider S, Zohlnhoefer D, Hoppe K, Schiemann M, Kennerknecht E, Sauer S, Schulz C, Kerstan S, Rudelius M,Seidl S, Sorge F, Langer H, Peluso M, Goyal P, Vestweber D, Emambokus NR, Busch DH, Frampton J, Gawaz: Platelets secrete stromal cell-derived factor 1alpha and recruit bonemarrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med. 2006 May 15;203(5):1221-33

Massberg S, Sausbier M, Klatt P, Bauer M, Pfeifer A, Siess W, Faessler R, Ruth P, Krombach F, Hofmann F: Increased Adhesion and Aggregation of Platelets Lacking Cyclic Guanosine 3',5'-Monophosphate Kinase I. J Exp Med. 1999, 189:1255-63

Massberg S, Schaerli P, Knezevic-Maramica I, Koellnberger M, Tubo N, Moseman EA, Huff IV, Junt T, Wagers AJ, Mazo IB, von Andrian UH: Immunosurveillance by Hematopoietic Progenitor Cells Trafficking through Blood, Lymph, and Peripheral Tissues. Cell. 2007 Nov 30;131(5):994-1008

Massberg S, Schurzinger K, Lorenz M, Konrad I, Schulz C, Plesnila N, Kennerknecht E, Rudelius M, Sauer S, Braun S, Kremmer E, Emambokus NR, Frampton J, Gawaz M: Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation. 2005;112:1180-8

Massberg S, von Andrian UH: Fingolimod and sphingosine-1-phosphate--modifiers of lymphocyte migration. N Engl J Med. 2006 Sep 14;355(11):1088-91

Matsunari I, Schricke U, Bengel FM, Haase HU, Barthel P, Schmidt G, Nekolla SG, Schoemig A, Schwaiger M: Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes. Circulation 2000 101. 2579-2585

May AE, Kalsch T, Massberg S, Herouy Y, Schmidt R, Gawaz M: Engagement of glycoprotein IIb/IIIa (alpha(IIb)beta3) on platelets upregulates CD40L and triggers CD40L-dependent matrix degradation by endothelial cells. Circulation. 2002 Oct 15;106(16).2111-7

May AE, Neumann FJ, Preissner KT: The Relevance of Blood Cell-Vessel Wall Adhesive Interactions for Vascular Thrombotic Disease. Thromb Haemostasis, 1999, 82:962-70

May AE, Neumann FJ, Schoemig A, Preissner KT: VLA-4 (alpha(4) beta(1)) engagement defines a novel activation pathway for beta(2) integrin-dependent leukocyte adhesion involving the urokinase receptor. Blood 2000; 96. 506-13

May AE, Redecke V, Gruner S, Schmidt R, Massberg S, Miethke T, Ryba B, Prazeres Da Costa C, Schoemig A, Neumann FJ: Recruitment of Chlamydia pneumoniae-Infected Macrophages to the Carotid Artery Wall in Noninfected, Nonatherosclerotic Mice. Arterioscler Thromb Vasc Biol. 2003;23:789-94.

May AE, Schmidt R, Bulbul BO, Holderle M, Walther F, Schoemig A, Gawaz M, Klouche M: Plasminogen and matrix metalloproteinase activation by enzymatically modified low density lipoproteins in monocytes and smooth muscle cells. Thromb Haemost. 2005;93:710-5

May AE, Schmidt R, Kanse SM, Chavakis T, Stephens RW, Schoemig A, Preissner KT, Neumann FJ: Urokinase receptor surface expression regulates monocyte adhesion in acute myocardial infarction. Blood. 2002 Nov 15;100(10).3611-7

Mehilli J, Dibra A, Kastrati A, Pache J, Dirschinger J, Schoemig A: Intracoronary Drug-Eluting Stenting to Abrogate Restenosis in Small Arteries (ISAR-SMART 3) Study Investigators. Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels. Eur Heart J. 2006 Feb;27(3):260-6

Mehilli J, Kastrati A, Dirschinger J, Bollwein H, Neumann FJ, Schoemig A: Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting. JAMA 2000; 284. 1799-1805

Mehilli J, Kastrati A, Dirschinger J, Dotzer F, Pache J, Hausleiter J, Kramer W, Schuehlen H, Schoemig A: Comparison of stenting with balloon angioplasty for lesions of small coronary vessels in patients with diabetes mellitus. Am J Med. 2002 Jan;112(1).13-8

Mehilli J, Kastrati A, Dirschinger J, Dotzer F, Schuehlen H, Fleckenstein M, Neumann FJ, Schoemig A: A randomized trial comparing the hand-mounted JoStent with the premounted Multi-Link Duet stent in patients with coronary artery disease. Catheter Cardiovasc Interv 54 (2001) 414-419

Mehilli J, Kastrati A, Dirschinger J, Etzel L, Bollwein H, Pache J, Schuehlen H, von Beckerath N, Seyfarth M, Schmitt C, Schoemig A: Intracoronary stenting and angiographic results: Restenosis after direct stenting versus stenting with predilation in patients with symptomatic coronary artery disease (ISAR-DIRECT trial). Catheter Cardiovasc Interv. 2004;61:190-5

Mehilli J, Kastrati A, Dirschinger J, Pache J, Seyfarth M, Blasini R, Hall D, Neumann FJ, Schoemig A: Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention. JAMA. 2002 Jan 9;287(2).210-5

Mehilli J, Kastrati A, Schuehlen H, Dibra A, Dotzer F, von Beckerath N, Bollwein H, Pache J, Dirschinger J, Berger PP, Schoemig A: Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel. Circulation. 2004;110:3627-35

Mehilli J, Kastrati A, Wessely R, Dibra A, Hausleiter J, Jaschke B, Dirschinger J, Schoemig A: Intracoronary Stenting and Angiographic Restenosis -Test Equivalence Between 2 Drug-Eluting Stents (ISAR-TEST) TrialInvestigators. Randomized trial of a nonpolymer-based rapamycin-eluting stent versus apolymer-based paclitaxel-eluting stent for the reduction of late lumen loss. Circulation. 2006 Jan 17;113(2):273-9

Mehilli J, Ndrepepa G, Kastrati A, Nekolla SG, Markwardt C, Bollwein H, Pache J, Martinoff S, Dirschinger J, Schwaiger M, Schoemig A: Gender and myocardial salvage after reperfusion treatment in acute myocardial infarction. J Am Coll Cardiol. 2005;45:828-31

Mehilli J, Ndrepepa G, Kastrati A, Neumann FJ, ten Berg J, Bruskina O, Dotzer F, Seyfarth M, Pache J, Kufner S, Dirschinger J, Berger PB, Schoemig A: Sex and effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions results from Intracoronary Stenting and Antithrombotic Regimen. Rapid Early Action for Coronary Treatment 2 trial. Am Heart J. 2007 Jul;154(1):158.e1-7

Merl S, Michaelis C, Jaschke B, Vorpahl M, Seidl S, Wessely R: Targeting 2A protease by RNA interference attenuates coxsackieviral cytopathogenicity and promotes survival in highly susceptible mice. Circulation. 2005;111:1583-92

Merl S, Wessely R: Anti-coxsackieviral efficacy of RNA interference is highly dependent on genomic target selection and emergence of escape mutants. Oligonucleotides. 2007 Spring;17(1):44-53

Meyer TS, Martinoff S, Hadamitzky M, Will A, Kastrati A, Schoemig A, Hausleiter J: Improved noninvasive assessment of coronary artery bypass grafts with 64-slice computed tomographic angiography in an unselected patient population. J Am Coll Cardiol. 2007 Mar 6;49(9):946-50. Epub 2007 Feb 20

Moliterno DJ, Yakubov SJ, Di Battiste PM, Herrmann HC, Stone GW, Macaya C, Neumann FJ, Ardissino D, Bassand JP, Borzi L, Yeung AC, Harris KA, Demopoulos LA, Topol EJ: Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement. the TARGET follow-up study. Lancet. 2002 Aug 3;360(9330).355-60

Montalescot G, Antoniucci D, Kastrati A, Neumann FJ, Borentain M, Migliorini A, Boutron C, Collet JP, Vicaut E: Abciximab in primary coronary stenting of ST-elevation myocardial infarction a European meta-analysis on individual patients' data with long-term follow-up. Eur Heart J. 2007 Feb;28(4):443-9

Moosmang S, Haider N, Klugbauer N, Adelsberger H, Langwieser N, Muller J, Stiess M, Marais E, Schulla V, Lacinova L, Goebbels S, Nave KA, Storm DR, Hofmann F, Kleppisch T: Role of hippocampal Cav1.2 Ca2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory. J Neurosci. 2005;25:9883-92

Moretti A, Caron L, Nakano A, Lam JT, Bernshausen A, Chen Y, Qyang Y, BuL, Sasaki M, Martin-Puig S, Sun Y, Evans SM, Laugwitz KL, Chien KR: Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell. 2006 Dec 15;127(6):1151-65

Moretti A, Lam J, Evans SM, Laugwitz KL: Biology of Isl1+ cardiac progenitor cells in development and disease. Cell Mol Life Sci. 2007 Mar;64(6):674-82

Moretti A, Weig HJ, Ott T, Seyfarth M, Holthoff HP, Grewe D, Gillitzer A, Bott-Fluegel L, Schoemig A, Ungerer M, Laugwitz KL: Essential myosin light chain as a target for caspase-3 in failing myocardium. Proc Natl Acad Sci U S A. 2002 Sep 3;99(18).11860-5

Mueller I, Andrassy P, Firschke C: Left ventricular pseudoaneurysm. a mechanical complication of acute myocardial infarction. Heart. 2002 Jun;87(6).569

Mueller I, Besta F, Schulz C, Massberg S, Schoemig A, Gawaz M: Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb Haemost. 2003;89:783-7.

Mueller I, Massberg S, Zierhut W, Binz C, Schuster A, Rudiger-von Hoch S, Braun S, Gawaz M: Effects of aspirin and clopidogrel versus oral anticoagulation on platelet function and on coagulation in patients with nonvalvular atrial fibrillation (CLAFIB). Pathophysiol Haemost Thromb. 2002 Jan-Feb;32(1).16-24

Mueller I, Seyfarth M, Ruediger S, Wolf B, Pogatsa-Murray G, Schoemig A, Gawaz M: Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement. Heart 85 (2001) 92-93

Ndrepepa G, Braun S, Dibra A, Mehilli J, Vogt W, Schoemig A, Kastrati A: Iron status and clinical outcome in patients with coronary artery disease after coronary stenting. Nutr Metab Cardiovasc Dis. 2005;15:418-25

Ndrepepa G, Braun S, Kastrati A, Schoemig A: Area under ROC curve, sensitivity, specificity of N-terminal probrain natriuretic peptide in predicting mortality in various subsets of patients with ischemic heart disease. Clin Res Cardiol. 2007 Oct;96(10):763-5

Ndrepepa G, Braun S, Mehilli J, Niemoller K, Schoemig A, Kastrati A: A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes. Clin Res Cardiol. 2006 Oct 30

Ndrepepa G, Braun S, Mehilli J, Niemoller K, Schoemig A, Kastrati A: A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes. Clin Res Cardiol. 2007 Jan;96(1):30-7

Ndrepepa G, Braun S, Mehilli J, Schoemig A, Kastrati A: Accuracy ofN-Terminal Probrain Natriuretic Peptide to Predict Mortality or Detect Acute Ischemia in Patients with Coronary Artery Disease. Cardiology. 2007 Sep 17;109(4):249-257

Ndrepepa G, Braun S, Mehilli J, von Beckerath N, Nekolla S, Vogt W, Schwaiger M, Schoemig A, Kastrati A: N-terminal pro-brain natriuretic peptide on admission in patients with acute myocardial infarction and correlation with scintigraphic infarct size, efficacy of reperfusion, and prognosis. Am J Cardiol. 2006 Apr 15;97(8):1151-6

Ndrepepa G, Braun S, Mehilli J, von Beckerath N, Vogt W, Schoemig A, Kastrati A: Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction. Am J Cardiol. 2005;95:553-7

Ndrepepa G, Braun S, Niemoller K, Mehilli J, von Beckerath N, von Beckerath O, Vogt W, Schoemig A, Kastrati A: Prognostic value of N-terminal pro-brain natriuretic peptide in patients with chronic stable angina. Circulation. 2005;112:2102-7

Ndrepepa G, Braun S, Schoemig A, Kastrati A: Accuracy of N-terminal pro-brain natriuretic peptide to predict mortality in various subsets of patients with coronary artery disease. Am J Cardiol. 2007 Aug 15;100(4):575-8

Ndrepepa G, Braun S, von Beckerath N, Mehilli J, Gorchakova O, Vogt W, Schoemig A, Kastrati A: Oxidized low density lipoproteins, statin therapy and severity of coronary artery disease. Clin Chim Acta. 2005;360:178-86

Ndrepepa G, Karch MR, Schneider MA, Weyerbrock S, Schreieck J, Deisenhofer I, Zrenner B, Schoemig A, Schmitt C: Characterization of paroxysmal and persistent atrial fibrillation in the human left atrium during initiation and sustained episodes. J Cardiovasc Electrophysiol. 2002 Jun;13(6).525-32

Ndrepepa G, Kastrati A, Braun S, Koch W, Kolling K, Mehilli J, Schoemig A: A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease. Clin Chim Acta. 2006 Nov;373(1-2):70-6

Ndrepepa G, Kastrati A, Braun S, Koch W, Kolling K, Mehilli J, Schoemig A: Circulating homocysteine levels in patients with type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis. 2006 Oct 4

Ndrepepa G, Kastrati A, Braun S, Mehilli J, Niemoller K, von Beckerath N, von Beckerath O, Vogt W, Schoemig A: N-terminal probrain natriuretic peptide and C-reactive protein in stablecoronary heart disease. Am J Med. 2006 Apr;119(4):355.e1-8

Ndrepepa G, Kastrati A, Mehilli J, Neumann FJ, Berg JT, Bruskina O, Dotzer F, Seyfarth M, Pache J, Dirschinger J, Berger PB, Schoemig A: One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel results of the ISAR-REACT 2 randomized trial. Eur Heart J. 2007 Dec 23

Ndrepepa G, Kastrati A, Mehilli J, Neumann FJ, ten Berg J, Bruskina O, Dotzer F, Seyfarth M, Pache J, Dirschinger J, Ulm K, Berger PB, Schoemig A: Age-dependent effect of abciximab in patients with acute coronary syndrome streated with percutaneous coronary interventions. Circulation. 2006 Nov 7;114(19):2040-6

Ndrepepa G, Kastrati A, Neumann FJ, Schmitt C, Mehilli J, Schoemig A: Five-year outcome of patients with acute myocardial infarction enrolled in a randomised trial assessing the value of abciximab during coronary artery stenting. Eur Heart J. 2004;25:1635-40

Ndrepepa G, Kastrati A, Schwaiger M, Mehilli J, Markwardt C, Dibra A, Dirschinger J, Schoemig A: Relationship between residual blood flow in the infarct-related artery and scintigraphic infarct size, myocardial salvage, and functional recovery in patients with acute myocardial infarction. J Nucl Med. 2005;46:1782-8

Ndrepepa G, Mehilli J, Bollwein H, Pache J, Schoemig A, Kastrati A: Sex-associated differences in clinical outcomes after coronary stenting in patients with diabetes mellitus. Am J Med. 2004;117:830-6

Ndrepepa G, Mehilli J, Martinoff S, Schwaiger M, Schoemig A, Kastrati A: Evolution of left ventricular ejection fraction and its relationship to infarct size after acute myocardial infarction. J Am Coll Cardiol. 2007 Jul 10;50(2):149-56

Ndrepepa G, Mehilli J, Schwaiger M, Nekolla S, Schmitt C, Dirschinger J, Schoemig A, Kastrati A: Myocardial salvage after reduced-dose thrombolysis combined with glycoprotein IIb/IIIa blockade versus thrombolysis alone in patients with acute myocardial infarction. J Thromb Thrombolysis. 2004;17:191-7

Ndrepepa G, Mehilli J, Schwaiger M, Schuehlen H, Nekolla S, Martinoff S, Schmitt C, Dirschinger J, Schoemig A, Kastrati A: Prognostic value of myocardial salvage achieved by reperfusion therapy in patients with acute myocardial infarction. J Nucl Med. 2004;45:725-9

Ndrepepa G, Schneider MA, Karch MR, Weber S, Schreieck J, Schoemig A, Schmitt C: Pulmonary vein internal electrical activity does not contribute to the maintenance of atrial fibrillation. Pacing Clin Electrophysiol. 2003;26:1356-62.

Ndrepepa G, Schneider MA, Karch MR, Weber S, Schreieck J, Zrenner B, Schmitt C: Impact of atrial fibrillation on the voltage of bipolar signals acquired from the left and right atria. Pacing Clin Electrophysiol. 2003;26:862-9.

Ndrepepa G, Schneider MA, Vallaint A, Zrenner B, Karch MR, Schreieck J, Henke J, Schoemig A, Schmitt C: Acute electrophysiologic effects and antifibrillatory actions of the long linear lesions in the right atrium in a sheep model. J Interv Card Electrophysiol 2000; 4. 529-536

Ndrepepa G, Schoemig A, Kastrati A: Lack of benefit from nitric oxide synthase inhibition in patients with cardiogenic shock looking for the reasons. Jama. 2007 Apr 18;297(15):1711-3. No abstract available

Ndrepepa G, Weber S, Karch MR, Schneider MA, Schreieck J, Schoemig A, Schmitt C: Electrophysiologic characteristics of the spontaneous onset and termination of atrial fibrillation. Am J Cardiol. 2002 Dec 1;90(11).1215-20

Ndrepepa G, Weber S, Schmitt C: Mapping studies in atrial fibrillation. Herzschr Elektrophys. 2002 13.186-94

Ndrepepa G, Zrenner B, Deisenhofer I, Karch M, Schneider M, Schreieck J, Schmitt C: Relationship between surface electrocardiogram characteristics and endocardial activation sequence in patients with typical atrial flutter. Z Kardiol 2000; 89. 527-537

Ndrepepa G, Zrenner B, Schreieck J, Karch MR, Schneider MA, Schoemig A, Schmitt C: Left atrial fibrillation with regular right atrial activation and a single left-to-right electrical interatrial connection. multisite mapping of dissimilar atrial rhythms. J Cardiovasc Electrophysiol. 2000; 11. 587-592

Neumann FJ, Hochholzer W, Pogatsa-Murray G, Schoemig A, Gawaz M: Antiplatelet effects of abciximab, tirofiban and eptifibatide in patients undergoing coronary stenting.  J Am Coll Cardiol 37 (2001) 1323-1328

Neumann FJ, Kastrati A, Miethke T, Mehilli J, Pogatsa-Murray G, Koch W, Seyfarth M, Schoemig A: Previous cytomegalovirus infection and restenosis after coronary stent placement Circulation 104 (2001)1135-1139

Neumann FJ, Kastrati A, Miethke T, Pogatsa-Murray G, Mehilli J, Valina C, Jogethaei N, da Costa CP, Wagner H, Schoemig A: Effect of antibiotic treatment against Chlamydia pneumoniae with roxithromycin on neointima proliferation after coronary stent placement. Lancet 257 (2001) 2085-89

Neumann FJ, Kastrati A, Miethke T, Pogatsa-Murray G, Seyfarth M, Schoemig A: Previous cytomegalovirus infection and risk of coronary thrombotic events after stent placement. Circulation. 2000; 101. 11-13

Neumann FJ, Kastrati A, Schmitt C, Blasini R, Hadamitzky M, Mehilli J, Gawaz M, Schleef M, Seyfarth M, Dirschinger J, Schoemig A: Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction. J Am Coll Cardiol 2000 15; 35. 915-921

Neumann FJ, Zohlnhoefer D, Fakoury L, Ott I, Gawaz M, Schoemig A: Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leucocyte interaction and surface expression of the leukocyte Mac-1 in acute myocardial infarction. J Am Coll Cardiol, 1999, 34:1420-6

Nuehrenberg TG, Langwieser N, Schwarz JB, Hou Y, Frank P, Sorge F, Matschurat S, Seidl S, Schoemig A, Clauss MA, Zohlnhoefer D: EMAP-II downregulation contributes to the beneficial effects of Rapamycin after vascular injury. Cardiovasc Res. 2007 Nov 20

Nuehrenberg TG, Voisard R, Fahlisch F, Rudelius M, Braun J, Gschwend J, Kountides M, Herter T, Baur R, Hombach V, Baeuerle PA, Zohlnhoefer D: Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty. Faseb J. 2005;19:246-8

Oellerich MF, Jacobi CA, Freund S, Niedung K, Bach A, Heesemann J, Truelzsch K: Yersinia enterocolitica infection of mice reveals clonal invasion and abscess formation. Infect Immun. 2007 Aug; 75 (8) 3802-11

Ott I: Tissue factor pathway inhibitor revisited. J Thromb Haemost. 2004;2:2246-8

Ott I: Soluble tissue factor emerges from inflammation. Circ Res. 2005;96:1217-8

Ott I, Andrassy M, Zieglgaensberger D, Geith S, Schoemig A, Neumann FJ: Regulation of monocytic procoagulant activity in acute myocardial infarction. Role of tissue factor and tissue factor pathway inhibitor-1. Blood 97 (2001) 3721-3726

Ott I, Keller U, Knoedler M, Gotze KS, Doss K, Fischer P, Urlbauer K, Debus G, von Bubnoff N, Rudelius M, Schoemig A, Peschel C, Oostendorp RA: Endothelial-like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction. Faseb J. 2005;19:992-4

Ott I, Koch W, von Beckerath N, de Waha R, Malawaniec A, Mehilli J, Schoemig A, Kastrati A: Tissue factor promotor polymorphism -603 A/G is associated with myocardial infarction. Atherosclerosis. 2004;177:189-91

Ott I, Malcouvier V, Schoemig A, Neumann FJ: Proteolysis of tissue factor pathway inhibitor-1 by thrombolysis in acute myocardial infarction. Circulation. 2002 Jan 22;105(3).279-81

Ott I, Michaelis C, Schuermann M, Steppich B, Seitz I, Dewerchin M, Zohlnhoefer D, Wessely R, Rudelius M, Schoemig A, Carmeliet P: Vascular remodeling in mice lacking the cytoplasmic domain of tissue factor. Circ Res. 2005;97:293-8

Ott I, Miyagi Y, Miyazaki K, Heeb MJ, Mueller BM, Rao LV, Ruf W: Reversible regulation of tissue factor-induced coagulation by glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol 2000; 20. 874-882

Ott I, Weigand B, Michl R, Seitz I, Sabbari-Erfani N, Neumann FJ, Schoemig A: Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38. Circulation. 2005;111:349-55

Overbeck M, Kolb C, Schmitt C, Schoemig A, Lange R: Accidental transarterial implantation of dual chamber pacemaker leads in the left ventricle and the right coronary artery. Pacing Clin Electrophysiol. 2005;28:469-71

Pache J, Dibra A, Mehilli J, Dirschinger J, Schoemig A, Kastrati A: Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial. Eur Heart J. 2005;26:1262-8

Pache J, Dibra A, Schaut C, Schuhlen H, Dirschinger J, Mehilli J, Kastrati A, Schoemig A: Sustained increased risk of adverse cardiac events over 5 years after implantation of gold-coated coronary stents. Catheter Cardiovasc Interv. 2006 Nov;68(5):690-5

Pache J, Kastrati A, Mehilli J, Bollwein H, Ndrepepa G, Schuehlen H, Martinoff S, Seyfarth M, Nekolla S, Dirschinger J, Schwaiger M, Schoemig A: A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy. Am Heart J. 2004;148:e3

Pache J, Kastrati A, Mehilli J, Gawaz M, Neumann FJ, Seyfarth M, Hall D, Braun S, Dirschinger J, Schoemig A: Clopidogrel therapy in patients undergoing coronary stenting. value of a high-loading-dose regimen. Catheter Cardiovasc Interv. 2002 Apr;55(4).436-41

Pache J, Kastrati A, Mehilli J, Schuehlen H, Dotzer F, Hausleiter J, Fleckenstein M, Neumann FJ, Sattelberger U, Schmitt C, Mueller M, Dirschinger J, Schoemig A: Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol. 2003;41:1283-8.

Parodi G, Ndrepepa G, Kastrati A, Conti A, Mehilli J, Sciagrà R, Schwaiger M, Antoniucci D, Schoemig A: Beyond 12 hours Reperfusion AlternatiVe Evaluation(BRAVE-2) Trial Investigators. Ability of mechanical reperfusion to salvage myocardium in patients with acute myocardial infarction presenting beyond 12 hours after onset of symptoms. Am Heart J. 2006 Dec;152(6):1133-9

Paschalidis M, Theiss W, Kolling K, Busch R, Schoemig A: Randomised comparison of manual compression repair versus ultrasound guided compression repair of postcatheterisation femoral pseudoaneurysms. Heart. 2006 Feb;92(2):251-2

Pflaumer A, Deisenhofer I, Hausleiter J, Zrenner B: Mapping and ablation of atypical flutter in congenital heart disease with a novel three-dimensional mapping system (Carto Merge). Europace. 2006 Feb;8(2):138-9

Pflaumer A, Hessling G, Luik A, Wu J, Zrenner B: Remote magnetic catheter mapping and ablation of permanent junctional reciprocating tachycardia in a seven-year-old child. J Cardiovasc Electrophysiol. 2007 Aug;18(8):882-5

Pinkau T, Hilgers KF, Veelken R, Mann JF: How does minor renal dysfunction influence cardiovascular risk and the management of cardiovascular disease. J Am Soc Nephrol. 2004;15:517-23

Pinkau T, Mann JF, Ndrepepa G, Mehilli J, Hadamitzky M, Braun S, Kastrati A, Schoemig A: Coronary revascularization in patients with renal insufficiency: restenosis rate and cardiovascular outcomes. Am J Kidney Dis. 2004;44:627-35

Plewan A, Alt E: Internal cardioversion of atrial fibrillation. new information.  Cardiac Electrophysiology Review 5 (2001) 201-205

Plewan A, Lehmann G, Ndrepepa G, Schreieck J, Schoemig A, Alt EU, Schmitt C: Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; Sotalol vs. Bisoprolol. Eur Heart J 22 (2001) 1504-1510

Plewan A, Valina C, Herrmann R, Alt E: Initial experience with a new balloon guided single lead catheter for internal cardioversion of atrial fibrillation and dual chamber pacing. PACE 1999; 22:228-32

Pogatsa-Murray G, Gawaz M: Durchflußzytometrische Analyse thrombozytärer Membranglykoproteine bei Sepsis. Anasth. Intensivmed 1999, 1:39-43

Ponimaskin E, Bareesel KK, Markgraf K, Reszka R, Lehmann K, Gelderblom HR, Gawaz M, Schmidt MF: Sendai virosomes revisited. reconstitution with exogenous lipids leads to potent vehicles for gene transfer. Virology 2000 10; 269. 391-403

Poppert H, Wolf O, Resch M, Theiss W, Schmidt-Thieme T, Graefin von Einsiedel H, Heider P, Martinoff S, Sander D: Differences in number, size and location of intracranial microembolic lesions after surgical versus endovascular treatment without protection device of carotid artery stenosis. J Neurol. 2004;251:1198-203

Prazeres Da Costa C, Neumann FJ, Kastrati A, Stallforth I, Schmid M, Joghetai N, Prebeck S, Wagner H, Miethke T: Role of IgG-seropositivity to Chlamydia pneumoniae in early thrombotic events after coronary stent placement. Atherosclerosis. 2003;166:171-6.

Preissler G, Massberg S, Waldner H, Messmer K: Intermittent capillary perfusion in rat pancreas grafts following short- and long-term preservation in University of Wisconsin solution. Transpl Int. 2006 Apr;19(4):325-32

Preissner KT, Kanse SM, May AE: Urokinase receptor. a molecular organizer in cellular communication. Curr Opin Cell Biol 2000; 12. 621-628

Reeker W, Sader R, Hauck RW, Kochs E: Translanryngeale Tracheostomie bei Morbus Bechterew und Guillain-Barré-Syndrom. Anästhesiol. Intensivmed. Notfallmed. Schmerzther. 1999, 34:665-7

Rexhepaj N, Bajraktari G, Berisha I, Beqiri A, Shatri F, Hima F, Elezi S, Ndrepepa G: Left and right ventricular diastolic functions in patients with rheumatoidarthritis without clinically evident cardiovascular disease. Int J Clin Pract. 2006 Jun;60(6):683-8

Rhee JS, Santoso S, Herrmann M, Bierhaus A, Kanse SM, May AE, Nawroth PP, Colman RW, Preissner KT, Chavakis T: New aspects of integrin-mediated leukocyte adhesion in inflammation: regulation by haemostatic factors and bacterial products. Curr Mol Med. 2003;3:387-92.

Ribeiro AL, Schmidt G, Sousa MR, Lombardi F, Gomes ME, Perez AA, Barros MV, Machado FS, Rocha MO: Heart rate turbulence in Chagas disease. Pacing Clin Electrophysiol. 2003;26:406-10.

Ribichini F, Joner M, Ferrero V, Finn AV, Crimins J, Nakazawa G, Acampado E, Kolodgie FD, Vassanelli C, Virmani R: Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis. J Am Coll Cardiol. 2007 Jul 10;50(2):176-85. Epub 2007 Jun 22

Riedel M: [Disorders of the pulmonary lymphatic system]. Vnitr Lek. 2002 Feb;48(2).147-50.

Riedel M: Acute pulmonary embolism 1. pathophysiology, clinical presentation, and diagnosis. Heart 85 (2001) 229-240

Riedel M: Acute pulmonary embolism 1. pathophysiology, clinical presentation, and diagnosis. Heart 85 (2001) 229-240

Riedel M: Clinical features of pulmonary embolism (in Czech). Vnitr Lek 2000; 46(12). 874-880

Riedel M: Diagnosis of pulmonary embolism (in Czech). Vnitr Lek 2000; 46(12). 874-880

Riedel M: Emergency diagnosis of pulmonary embolism. Heart 85 (2001) 607-609

Riedel M: Genetics and pathogenesis of primary pulmonary hypertension. (in Czech) Cor Vasa 2001; 43(8). 415-418

Riedel M: Multiple effusions and lymphedema in the yellow nail syndrome. Circulation. 2002 Jan 22;105(3).E25-6

Riedel M: Nonthrombotic pulmonary embolism. (in Czech) Vnitr Lek 47 (2001) 391-396

Riedel M: Diagnosing pulmonary embolism. Postgrad Med J. 2004;80:309-19. Riedel M. Scimitar syndrome. Lancet. 2004;363:356

Riedel M, Bohanes VZ: Kardiol. 2002 Aug;91(8).605-13

Riedel M, Martinoff S, Hausleiter J, Bohanes V, Engelke C: [Paracardiac infiltrate or Turkish sword?]. Pneumologie. 2003;57:78-82.

Riedel M, Schulz C: Hodnocení funkcní operability nemocných s rakovinou plic. CAS. Lék. ces. 138, 1999, 10:301-9

Riedel M, Stein HJ, Mounyam L, Busch R, Siewert JR: Predictors for tracheobronchial invasion of suprabifurcal esophageal cancer. Respir 2000; 67.630-637

Riedel M, Stein HJ, Mounyam L, Lembeck R, Siewert JR: Bronchoscopy in the preoperative staging of oesophageal cancer below the tracheal bifurcation. a prospective study. Eur Respir J 2000; 16. 134-139

Riedel M, Stein HJ, Mounyam L, Lembeck R, Siewert JR: Extensive sampling improves preoperative bronchoscopic assessment of airway invasion by supracarinal esophageal cancer. A prospective study in 166 patients. Chest 119 (2001) 1652-1660

Riedel M, Stein HJ, Mounyam L, Zimmermann F, Fink U, Siewert JR: Influence of simultaneous neoadjuvant radiotherapy and chemotherapy on bronchoscopic findings and lung function in patients with locally advanced proximal esophageal cancer. Am J Respir Crit Care Med 2000; 162. 1741-1746

Rieger J, Hautmann H, Linsenmaier U, Weber C, Treitl M, Huber RM, Pfeifer KJ: Treatment of benign and malignant tracheobronchial obstruction with metal wire stents: experience with a balloon-expandable and a self-expandable stent type. Cardiovasc Intervent Radiol. 2004;27:339-43

Risius T, Lewalter T, Luderitz B, Schwab JO, Spitzer S, Schmitt C, Vester E, Rostock T, Meinertz T, Willems S: Transient ST-segment-elevation during pulmonary vein ablation using circumferential coiled microelectrodes in a prospective multi-centre study. Europace. 2006 Mar;8(3):178-81

Roggenland D, Schneider S, Klein HH, Kann PH: Endosonography - an additional diagnostic possibility in the differentiation between the two common types of primary hyperaldosteronism. Med Klin (Munich). 2006 Jan 15;101(1):65-8. German

Roithinger F, Karch M, Steiner PR, SippensGroenewegen A, Lesh MD: The Spatial Dispersion of Atrial Refractoriness and Atrial Fibrillation Vulnerability. J Interv Card Electrophysiol, 1999, 3:311-9 (in print für Dez.)

Roos M, Lutz J, Salmhofer H, Luppa P, Knauß A, Braun S, Martinoff S, Schoemig A, Heemann U, Kastrati A, Hausleiter J: Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function. Clin Endocrinol (Oxf). 2007 Oct 29

Ruf W, Fischer EG, Huang HY, Miyagi Y, Ott I, Riewald M, Mueller BM: Diverse functions of protease receptor tissue factor in inflammation and metastasis. Immunol Res 2000; 21. 289-292

Rupprecht HJ, vom Dahl J, Terres W, Seyfarth KM, Richardt G, Schultheibeta HP, Buerke M, Sheehan FH, Drexler H: Cardioprotective effects of the Na(+)/H(+) exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA. Circulation 2000 27; 101. 2902-2908

Sarafoff NI, Bieschke J, Giese A, Weber P, Bertsch U, Kretzschmar HA: Automated PrPres amplification using indirect sonication. J Biochem Biophys Methods. 2005;63:213-21

Schaefer A, Schulz C, Fraccarollo D, Tas P, Leutke M, Eigenthaler M, Seidl S, Heider P, Ertl G, Massberg S, Bauersachs J: The CX3C chemokine fractalkine induces vascular dysfunction by generation of superoxide anions. Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):55-62

Schafer A, Schulz C, Eigenthaler M, Fraccarollo D, Kobsar A, Gawaz M, Ertl G, Walter U, Bauersachs J: Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion. Blood. 2004;103:407-12

Schimpf R, Reents T, Hessling G, Deisenhofer I, Pflaumer A, Estner H, Wu J, Ucer E, Zrenner B, Sueselbeck T, Kuschyk J, Veltmann C, Borggrefe M, Wolpert C: Magnetic navigation in invasive electrophysiological diagnostic and therapy. Herzschrittmacherther Elektrophysiol. 2007 Sep;18(3):157-65

Schlueter T, Baum H, Plewan A, Neumeier D: Effects of implantable cardioverter defibrillator implantation and shock application on biochemical markers of myocardial damage.  Clin Chem 47 (2001) 459-463

Schmidt G, Malik M, Barthel P, Schneider R, Ulm K, Rolnitzky L, Camm AJ, Bigger JT Jr, Schoemig A: Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. The Lancet. 1999;353:1390-1396.

Schmidt G, Schneider R, Barthel P: Heart Rate Turbulence. Cardiac Electrophiosology Review 2000, 3. 297-302

Schmidt R, Bultmann A, Fischel S, Gillitzer A, Cullen P, Walch A, Jost P, Ungerer M, Tolley ND, Lindemann S, Gawaz M, Schoemig A, May AE: Extracellular Matrix Metalloproteinase Inducer (CD147) Is a Novel Receptor on Platelets, Activates Platelets, and Augments Nuclear Factor {kappa}B Dependent Inflammation in Monocytes. Circ Res. 2007 Nov 29

Schmidt R, Bultmann A, Ungerer M, Joghetaei N, Bulbul O, Thieme S,Chavakis T, Toole BP, Gawaz M, Schoemig A, May AE: Extracellular matrix metalloproteinase inducer regulates matrixmetalloproteinase activity in cardiovascular cells: implications in acutemyocardial infarction. Circulation. 2006 Feb 14;113(6):834-41

Schmidt R, Redecke V, Breitfeld Y, Wantia N, Miethke T, Massberg S, Fischel S, Neumann FJ, Schoemig A, May AE: EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture. Thromb Haemost. 2006 Jan;95(1):151-8

Schmieder S, Ndrepepa G, Dong J, Zrenner B, Schreieck J, Schneider MA, Karch MR, Schmitt C: Acute and long-term results of radiofrequency ablation of common atrial flutter and the influence of the right atrial isthmus ablation on the occurrence of atrial fibrillation. Eur Heart J. 2003;24:956-62.

Schmieder S, Schneider MA, Karch MR, Schmitt C: Internal low energy cardioversion of atrial fibrillation using a single lead system. comparison of a left and right pulmonary artery catheter approach. PACE 24 (2001) 1108-1112

Schmitt C: Herzinsuffizienz und plötzlicher Herztod-Medikamentöse und nichtmedikamentöse therapeutische Möglichkeiten aus der Sicht des Rhythmologen. Z Kardiol 2000, 89; Suppl 7. 55-59

Schmitt C: Vorhofflimmerablation. Herzschr Elektrophys. 2002 13.175-7

Schmitt C, Barthel P, Ndrepepa G, Schreieck J, Plewan A, Schoemig A, Schmidt G: Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasiv risk stratifiers. J Am Coll Cardiol 37 (2001) 1901-1907

Schmitt C, Estner H, Hecher B, Luik A, Kolb C, Karch M, Ndrepepa G, Zrenner B, Hessling G, Deisenhofer I: Radiofrequency ablation of complex fractionated atrial electrograms (CFAE) preferential sites of acute termination and regularization in paroxysmal and persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2007 Sep;18(10):1039-46

Schmitt C, Lehmann G, Schmieder S, Karch M, Neumann FJ, Schoemig A: Diagnosis of acute myocardial infarction in angiographically documented occluded infarct vessel limitations of ST-segment elevation in standard and extended ECG leads.  Chest 120 (2001) 1540-6

Schmitt C, Ndrepepa G, Deisenhofer I, Schneider M: Recent Advances in Cardiac Mapping Techniques. Current Cardiology Reports, 1999, I:149-56

Schmitt C, Ndrepepa G, Weber S, Schmieder S, Weyerbrock S, Schneider M, Karch MR, Deisenhofer I, Schreieck J, Zrenner B, Schoemig A: Biatrial multisite mapping of atrial premature complexes triggering onset of atrial fibrillation. Am J Cardiol. 2002 Jun 15;89(12).1381-7

Schmitt C, Zrenner B, Schneider M, Karch M, Ndrepepa G, Deisenhofer I, Weyerbrock S, Schreieck J, Schoemig A: Clinical Experience with a Novel Multielectrode Basket Cathether in Right Atrial Tachycardias. Circulation, 1999, 99:2414-22

Schneider MA, Ndrepepa G, Vallant A, Gayk U, Richter T, Henke J, Zrenner B, Karch MR, Erhardt W, Schoemig A, Schmitt C: Application of right atrial contiguous linear lesions. an in vivo efficacy validation of multipolar ablation catheters in an animal model. Pacing Clin Electrophysiol. 2002 Oct;25(10).1459-66

Schneider MA, Ndrepepa G, Weber S, Deisenhofer I, Schoemig A, Schmitt C: Influence of high-pass filtering on noncontact mapping and ablation of atrial tachycardias. Pacing Clin Electrophysiol. 2004;27:38-46

Schneider MA, Ndrepepa G, Zrenner B, Karch MR, Schreieck J, Deisenhofer I, Schmitt C: Noncontact mapping-guided catheter ablation of atrial fibrillation associated with left atrial ectopy. J Cardiovasc Electrophysiol 2000; 11. 475-479

Schneider MA, Schmitt C: [Non-contact mapping. a simultaneous spatial detection in the diagnosis of( arrhythmias]. Z Kardiol 2000; 89 Suppl 3. 177-185

Schneider MA, Zrenner B, Karch MR, Weyerbrock S, Schreieck J, Ndrepepa G, Schoemig A, Schmitt C: Direct and indirect catheter-to-catheter carbonization caused by high power radiofrequency delivery via a large tip ablation electrode. J Interv Cardiol. 2002 Oct;15(5).407-10

Schneider MAE, Nienaber CA: Lack of impact of myocardial ischemia on the signal-averaged ECG assessment by time-domain analysis. ANE. 2002 Jul;7(3).191-7

Schneider MAE, Schmitt C: Stellenwert des non-contact Mapping bei ventrikulären Tachykardien Herzschr. Elektrophys 2000, 111. 40-46

Schneider R, Barthel P, Bauer A, Schmidt G: A programing library for transparen access to physiological signals. Proceedings E-health in Common Europe. 2003:26.

Schneider R, Bauer A, Barthel P, Schmidt G: Challenge 2006: QT Interval Measurement. Computers in Cardiology 2006; 33:325-328

Schoemig A, Dibra A, Windecker S, Mehilli J, Suárez de Lezo J, Kaiser C, Park SJ, Goy JJ, Lee JH, Di Lorenzo E, Wu J, Jueni P, Pfisterer ME, Meier B, Kastrati A: A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol. 2007 Oct 2;50(14):1373-80

Schoemig A, Kastrati A: Long Lesions, Long Stents and the Long Process of Stent Optimization. J Am Coll Cardiol, 1999, 34:660-2

Schoemig A, Kastrati A: Distal embolic protection in patients with acute myocardial infarction: attractive concept but no evidence of benefit. Jama. 2005;293:1116-8

Schoemig A, Kastrati A, Dirschinger J, Mehilli J, Schricke U, Pache J, Martinoff S, Neumann FJ, Schwaiger M: Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. N Engl J Med 2000; 343. 385-391

Schoemig A, Kastrati A, Wessely R: Prevention of restenosis by systemic drug therapy: back to the future? Circulation. 2005;112:2759-61

Schoemig A, Mehilli J, Antoniucci D, Ndrepepa G, Markwardt C, Di Pede F, Nekolla SG, Schlotterbeck K, Schuehlen H, Pache J, Seyfarth M, Martinoff S, Benzer W, Schmitt C, Dirschinger J, Schwaiger M, Kastrati A: Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. Jama. 2005;293:2865-72

Schoemig A, Mehilli J, Holle H, Hosl K, Kastrati D, Pache J, Seyfarth M, Neumann FJ, Dirschinger J, Kastrati A: Statin treatment following coronary artery stenting and one-year survival. J Am Coll Cardiol. 2002 Sep 4;40(5).854-61

Schoemig A, Ndrepepa G, Kastrati A: Late myocardial salvage: time to recognize its reality in the reperfusiontherapy of acute myocardial infarction. Eur Heart J. 2006 Aug;27(16):1900-7

Schoemig A, Ndrepepa G, Mehilli J, Dirschinger J, Nekolla SG, Schmitt C, Martinoff S, Seyfarth M, Schwaiger M, Kastrati A: A randomized trial of coronary stenting versus balloon angioplasty as a rescue intervention after failed thrombolysis in patients with acute myocardial infarction. J Am Coll Cardiol. 2004;44:2073-9

Schoemig A, Schmitt C, Dibra A, Mehilli J, Volmer C, Schuehlen H, Dirschinger J, Dotzer F, ten Berg JM, Neumann FJ, Berger PB, Kastrati A: One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel. Eur Heart J. 2005;26:1379-84

Schoemig K, Busch G, Steppich B, Sepp D, Kaufmann J, Stein A, Schoemig A, Ott I: Interleukin-8 is associated with circulating CD133+ progenitor cells in acutemyocardial infarction. Eur Heart J. 2006 May;27(9):1032-7

Schoemig K, Ndrepepa G, Mehilli J, Pache J, Kastrati A, Schoemig A: Thoracic radiotherapy in patients with lymphoma and restenosis after coronary stent placement. Catheter Cardiovasc Interv. 2007 Sep;70(3):359-65

Schoen P, Poerner M, Hausleiter J, Wacker A, Martinoff S, Kaemmerer H, Redington A, Hess J: Images in cardiovascular medicine. Multislice computed tomography in complex pulmonary atresia after stent implantation. Circulation. 2004;110:e299-300

Schreiber C, Hessling G, Zrenner B, Prodan Z, Lei L, Eicken A, Lange R: Three-dimensional electroanatomic voltage map-guided treatment of a patient with a failing atriopulmonary fontan circulation. Herz. 2007 Feb;32(1):58-61

Schreiber C, Hormoz M, Kolb C, Schmitt C: Modified Implantation of a Transvenous Defibrillator in a patient After Tricuspid Valve Replacement. PACE 2000; 23. 1698-1699

Schreieck J, Dostal S, von Beckerath N, Wacker A, Flory M, Weyerbrock S, Koch W, Schoemig A, Schmitt C: C825T polymorphism of the G-protein beta3 subunit gene and atrial fibrillation: association of the TT genotype with a reduced risk for atrial fibrillation. Am Heart J. 2004;148:545-50

Schreieck J, Ndrepepa G, Zrenner B, Schneider M, Weyerbrock S, Dong J, Schmitt C: Radiofrequency ablation of cardiac arrhythmias using a three-dimensional real-time position management and mapping system. Pacing Clin Electrophysiol. 2002 Dec;25(11).

Schreieck J, Richardt G: Endogenous Adenosine Reduces the Occurence of Ischemia-induced Ventricular Fibrillation in Rat Heart. J Mol Cell Cardiol, 1999, 31: 123-34

Schreieck J, Wang Y, Overbeck M, Schoemig A, Schmitt C: Altered transient outward current in human atrial myocytes of patients with reduced left ventricular function. J Cardiovasc Electrophysiol 2000; 11. 180-192

Schreieck J, Zrenner B, Deisenhofer I, Schmitt C: Rescue ablation of electrical storm in patients with ischemic cardiomyopathy: a potential-guided ablation approach by modifying substrate of intractable, unmappable ventricular tachycardias. Heart Rhythm. 2005;2:10-4

Schreieck J, Zrenner B, Dong J, Ndrepepa G, Schmitt C: Dissimilar atrial rhythms. coexistence of reentrant atrial tachycardia, atrioventricular nodal reentrant tachycardia and interatrial conduction block. Z Kardiol. 2002 Jan;91(1).68-73

Schreieck J, Zrenner B, Kolb C, Ndrepepa G, Schmitt C: Inappropriate shock delivery due to ventricular double detection with a biventricular pacing implantable cardioverter defibrillator. PACE 24 (2001) 1154-1157

Schreieck J, Zrenner B, Kumpmann J, Ndrepepa G, Schneider MA, Deisenhofer I, Schmitt C: Prospective randomized comparison of closed cooled-tip versus 8-mm-tip catheters for radiofrequency ablation of typical atrial flutter. J Cardiovasc Electrophysiol. 2002 Oct;13(10).980-5

Schuehlen H, Eigler NL, Whiting JS, Haubner R, Hausleiter J, Dirschinger J, Kastrati A, Schwaiger M, Schoemig A: Usefulness of intracoronary brachytherapy for in-stent restenosis with a 188Re-liquid-filled balloon. Am J Cardiol 87 (2001) 463-466, A7

Schuehlen H, Kastrati A: Should we routinely stent small coronary arteries? Emodinamica 27 (2001)

Schuehlen H, Kastrati A, Mehilli J, Hausleiter J, Pache J, Dirschinger J, Schoemig A: Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement. Am Heart J. 2004;147:317-22

Schuehlen H, Kastrati A, Pache J, Dirschinger J, Schoemig A: Sustained benefit over 4 years from an initial combined antiplatelet regimen after coronary stent placement in the ISAR trial Am J Cardiol 87 (2001) 397-400

Schuehlen H, Kastrati A, Pache J, Dirschinger J, Schoemig A: Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement. Analysis of 5678 patients with a four-week ticlopidine regimen J Am Coll Cardiol 37 (2001) 2066-2073

Schuehlen H, Kastrati A, Schoemig A: Small vessel stenting Cardiology International (2001)

Schuehlen H, Kastrati A, Schoemig A: Structural failure of a coronary stent Heart 86 (2001) 26

Schuhlen H, Kastrati A, Mehilli J, Hausleiter J, Dirschinger J, Dotzer F, Bollwein H, Schoemig A: Abciximab and angiographic restenosis after coronary stent placement. Analysis of the angiographic substudy of ISAR-REACT - a double-blind, placebo-controlled, randomized trial evaluating abciximab in patients undergoing elective percutaneous coronary interventions after pretreatment with a high loading dose of clopidogrel. Am Heart J. 2006 Jun;151(6):1248-54

Schulz C, Emslander HP, Riedel M: Beurteilung der funktionellen Operabilität von Patienten mit Bronchialkarzinom, Pneumologie 1999, 53: 337-47

Schulz C, Emslander HP, Riedel M: Risikoabschätzung von Patienten vor Lungenresektion. Chirurg, 1999, 70:664-73

Schulz C, Herrmann R, Rybnikar A, Alt E: Experimental results with a new gold coated multicellular stent design. Comparison with a modified slotted tube stent using the coronary overstretch model of the pig. J Interv Cardiol 1999; 12:191-8

Schulz C, Herrmann RA, Beilharz C, Pasquantonio J, Alt E: Coronary stent symmetry and vascular injury determine experimental restenosis. Heart 2000; 83. 462-467

Schulz C, Kress W, Schoemig A, Wessely R: Endocardial cushion defect in a patient with Crouzon syndrome carrying a mutation in the fibroblast growth factor receptor (FGFR)-2 gene. Clin Genet. 2007 Oct. 72(4):305-7

Schulz C, Niederer C, Andres C, Herrmann RA, Lin X, Henkelmann R, Panzer W, Herrmann C, Regulla DF, Wolf I, Ulm K, Alt E: Endovascular irradiation from beta-particle-emitting gold stents results in increased neointima formation in a porcine restenosis model. Circulation 2000;101.1970-1975

Schulz C, Schaefer A, Stolla M, Kerstan S, Lorenz M, von Bruehl ML, Schiemann M, Bauersachs J, Gloe T, Busch DH, Gawaz M, Massberg S: Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood a critical role for P-selectin expressed on activated platelets. Circulation. 2007 Aug 14;116(7):764-73

Schulz C, Schoemig A, Kastrati A: Acute coronary artery stent thrombosis following rapid renewal of functional platelets: implications for intensified antiplatelet therapy. Thromb Haemost. 2006 Sep;96(3):384-6

Seitz I, Hess S, Schulz H, Eckl R, Busch G, Montens HP, Brandl R, Seidl S, Schoemig A, Ott I: Membrane-type serine protease-1/matriptase induces interleukin-6 and -8 in endothelial cells by activation of protease-activated receptor-2 potential implications in atherosclerosis. Arterioscler Thromb Vasc Biol. 2007 Apr;27(4):769-75

Serruys PW, Ormiston JA, Sianos G, Sousa JE, Grube E, den Heijer P, de Feyter P, Buszman P, Schoemig A, Marco J, Polonski L, Thuesen L, Zeiher AM, Bett JH, Suttorp MJ, Glogar HD, Pitney M, Wilkins GT, Whitbourn R, Veldhof S, Miquel K, Johnson R, Coleman L: Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial. J Am Coll Cardiol. 2004;44:1363-7

Seyfarth M, Schoemig A: Right ventricular involvement in acute myocardial infarction. Internist (Berl). 2004;45:1117-24

Shah DC, Haissaguerre M, Jais P, Hocini M, Yamane T, Deisenhofer I, Garrigue S, Clementy J: Electrophysiologically guided ablation of the pulmonary veins for the curative treatment of atrial fibrillation. Ann Med 2000; 32. 408-416

Sibbing D, Barthel P, Abbrederis K, Dennig K, Gaa J: Intracardiac right ventricular metastatic tumor of malignant T-cell lymphoma. Int J Cardiol. 2007 Apr 25;117(2):e84-5. Epub 2007 Feb 27

Sibbing D, Overbeck M, Schmidt R, Gaa J, Barthel P: Patent for a men ovale with a riding vermicular thrombus causing paradoxical and massive pulmonary embolism. Eur Heart J. 2006 Nov;27(22):2724

Sibbing D, von Beckerath O, Schoemig A, Kastrati A, von Beckerath N: Diabetes mellitus and platelet function after administration of aspirin and a single 600 mg dose of clopidogrel. J Thromb Haemost. 2006 Dec;4(12):2566-8

Sibbing D, von Beckerath O, Schoemig A, Kastrati A, von Beckerath N: P2Y1 gene A1622G dimorphism is not associated with adenosinediphosphate-induced platelet activation and aggregation after administration ofa single high dose of clopidogrel. J Thromb Haemost. 2006 Apr;4(4):912-4

Sibbing D, von Beckerath O, Schoemig A, Kastrati A, von Beckerath N: Impact of body mass index on platelet aggregation after administration of a high loading dose of 600 mg of clopidogrel before percutaneous coronary intervention. Am J Cardiol. 2007 Jul 15;100(2):203-5

Sibbing D, von Beckerath O, Schoemig A, Kastrati A, von Beckerath N: Platelet function in clopidogrel-treated patients with acute coronary syndrome. Blood Coagul Fibrinolysis. 2007 Jun;18(4):335-9

Sibbing D, von Beckerath O, von Beckerath N, Koch W, Mehilli J, Schwaiger M, Schoemig A, Kastrati A: Plasminogen activator inhibitor-1 4G/5G polymorphism and efficacy of reperfusion therapy in acute myocardial infarction. Blood Coagul Fibrinolysis. 2005;16:511-5

Simoes MV, Barthel P, Matsunari I, Nekolla SG, Schoemig A, Schwaiger M, Schmidt G, Bengel FM: Presence of sympathetically denervated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction. Eur Heart J. 2004;25:551-7

Sotgia B, Sciagrà R, Parodi G, Kastrati A, Antoniucci D, Schoemig A, Pupi A: Estimate of myocardial salvage in late presentation acute myocardial infarction by comparing functional and perfusion abnormalities in predischarge gated SPECT. Eur J Nucl Med Mol Imaging. 2007 Dec 11

Spath M, Schroder M, Schlotter-Weigel B, Walter MC, Hautmann H, Leinsinger G, Pongratz D, Muller-Felber W: The long-term outcome of anti-Jo-1-positive inflammatory myopathies. J Neurol. 2004;251:859-64

Stein A, Busch G, Schoemig K, Deisenhofer I, Estner H, Zrenner B, Schmitt C, Braun SL, Schoemig A, Ott I: Systemic inflammatory changes after pulmonary vein radiofrequency ablation do not alter stem cell mobilization. Circulation (Supplement) Vol 18, II-704

Steinhubl SR, Kastrati A, Berger PB: Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugs. Am Heart J. 2007 Jul;154(1):3-11

Steppich B, Mattisek C, Sobczyk D, Kastrati A, Schoemig A, Ott I: Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction. Thromb Haemost. 2005;93:35-9

Steppich BA, Moog P, Matissek C, Wisniowski N, Kuehle J, Joghetaei N, Neumann FJ, Schoemig A, Ott I: Cytokine profiles and T cell function in acute coronary syndromes. Atherosclerosis. 2007 Feb;190(2):443-51

Steppich BA, Moog P, Matissek C, Wisniowski N, Kuhle J, Joghetaei N, Neumann FJ, Schoemig A, Ott I: Cytokine profiles and T cell function in acute coronary syndromes. Atherosclerosis. 2006 Mar 25

Steppich BA, Ott I: Tissue factor in acute coronary syndromes. Hamostaseologie. 2006 May; 26(2):147-53. Review. German

Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schoemig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ: Outcomes associated with drug-eluting and bare-metal stents a collaborative network meta-analysis. Lancet. 2007 Sep 15;370(9591):937-48. Review

Stone GW, Moliterno DJ, Bertrand M, Neumann FJ, Herrmann HC, Powers ER, Grines CL, Moses JW, Cohen DJ, Cohen EA, Cohen M, Wolski K, Di Battiste PM, Topol EJ: Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting. the TARGET Trial. Circulation. 2002 May 21;105(20).2347-54

Taubert D, Kastrati A, Harlfinger S, Gorchakova O, Lazar A, von Beckerath N, Schoemig A, Schoemig E: Pharmacokinetics of clopidogrel after administration of a high loading dose. Thromb Haemost. 2004;92:311-6

Taubert D, von Beckerath N, Grimberg G, Lazar A, Jung N, Goeser T, Kastrati A, Schoemig A, Schoemig E: Impact of P-glycoprotein on clopidogrel absorption. Clin Pharmacol Ther. 2006 Nov;80(5):486-501

Theiss W, Hermanek P, Mathias K, Ahmadi R, Heuser L, Hoffmann FJ, Kerner R, Leisch F, Sievert H, von Sommoggy S: Pro-CAS: a prospective registry of carotid angioplasty and stenting. Stroke. 2004;35:2134-9

Theiss W, Schreiber K, Schoemig A: Manual compression repair of post-catheterization femoral pseudoaneurysms. an alternative to ultrasound guided compression repair?. Vasa. 2002 May;31(2).95-9

Tiroch K, von Beckerath N, Koch W, Lengdobler J, Joost A, Schoemig A, Kastrati A: Interferon-gamma and interferon-gamma receptor 1 and 2 gene polymorphisms and restenosis following coronary stenting. Atherosclerosis. 2005;182:145-51

Toelg R, Schreieck J, Kurz T, Katus HA, Richardt G: Ischemia-induced ventricular fibrillation in isolated perfused rat heart. role of alpha1A-adrenoceptor mediated activation of protein kinase C. Basic Res Cardiol 96 (2001) 68-74

Topol EJ, Moliterno DJ, Herrmann HC, Powers ER, Grines CL, Cohen DJ, Yakubov SJ, Cohen EA, Bertrand M, Neumann FJ, Stone GW, Di Battiste PM, Demopoulos LA: Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for prevention of ischemic events with percutaneous coronary intervention. New Engl J Med 344 (2001) 1888-94

Tousek P, Orban M, Schoemig A, Firschke C: Images in cardiovascular medicine. Real-time perfusion echocardiography of an intracardiac mass. Circulation. 2003;107:2390.

Truelzsch K, Oellerich MF, Heesemann J: Invasion and dissemination of Yersinia enterocolitica in the mouse infection model. Adv Exp Med Biol. 2007; 603 279-85

Tuchnitz A, Schmitt C, von Bibra H, Schneider M, Plewan A, Schoemig A: Noninvasive Localization of Accessory Pathways in Patients with Wolff-Parkinson-White-Syndrome with the Use of Myocardial Doppler Imaging; Journal of the American Society of Echocardiography, 1999,12:32-40,

Tundo F, Lombardi F, Rocha MC, Botoni F, Schmidt G, Barros VC, Muzzi B, Gomes M, Pinto A, Ribeiro AL: Heart rate turbulence and left ventricular ejection fraction in Chagas disease. Europace. 2005;7:197-203

Ungerer M, Peluso M, Gillitzer A, Massberg S, Heinzmann U, Schulz C, Munch G, Gawaz M: Generation of functional culture-derived platelets from CD34+ progenitor cells to study transgenes in the platelet environment. Circ Res. 2004;95:e36-44

Ungerer M, Weig HJ, Kubert S, Overbeck M, Bengel FM, Schoemig A, Schwaiger M: Regional pre- and postsynaptic sympathetic system in the failing human heart--regulation of beta ARK-1. Eur J Heart Fail 2000; 2. 23-31

von Beckerath N, Kastrati A, Koch W, Boettiger C, Mehilli J, Seyfarth M, Schoemig A: G Protein beta3 subunit orphism and risk of thrombosis and restenosis following coronary stent placement. Atherosclerosis 2000; 149. 151-155

von Beckerath N, Kastrati A, Wieczorek A, Pogatsa-Murray G, Sibbing D, Graf I, Schoemig A: A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days. Eur Heart J. 2007 Aug;28(15):1814-9

von Beckerath N, Koch W, Mehilli J, Boettiger C, Braun S, Schoemig A, Kastrati A: Glycoprotein Ia C807T orphism and risk of restenosis following coronary stenting. Atherosclerosis 156 (2001) 463-8

von Beckerath N, Koch W, Mehilli J, Boettiger C, Schoemig A, Kastrati A: Glycoprotein Ia gene C807T orphism and risk for major adverse cardiac events within the first 30 days after coronary artery stenting. Blood 2000; 95. 3297-3301

von Beckerath N, Koch W, Mehilli J, Gorchakova O, Braun S, Schoemig A, Kastrati A: ABO locus O1 allele and risk of myocardial infarction. Blood Coagul Fibrinolysis. 2004;15:61-7

von Beckerath N, Nees S, Neumann FJ, Krebs B, Juchem G, Schoemig A: An inward rectifier and a voltage-dependent K+ current in single, cultured pericytes from bovine heart. Cardiovasc Res 2000; 46. 569-578

von Beckerath N, Pogatsa-Murray G, Wieczorek A, Sibbing D, Schoemig A, Kastrati A: Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsiveness. Thromb Haemost. 2006 May;95(5):910-1

von Beckerath N, Schusterschitz Y, Koch W, Griesser K, Mehilli J, Gorchakova O, Schoemig A, Kastrati A: G protein beta 3 subunit 825T allele carriage and risk of coronary artery disease. Atherosclerosis. 2003;167:135-9.

von Beckerath N, Taubert D, Pogatsa-Murray G, Schoemig E, Kastrati A, Schoemig A: Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial. Circulation. 2005;112:2946-50

von Beckerath N, Taubert D, Pogatsa-Murray G, Wieczorek A, Schoemig E, Schoemig A, Kastrati A: A patient with stent thrombosis, clopidogrel-resistance and failure to metabolize clopidogrel to its active metabolite. Thromb Haemost. 2005;93:789-91

von Beckerath N, von Beckerath O, Koch W, Eichinger M, Schoemig A, Kastrati A: P2Y12 gene H2 haplotype is not associated with increased adenosine diphosphate-induced platelet aggregation after initiation of clopidogrel therapy with a high loading dose. Blood Coagul Fibrinolysis. 2005;16:199-204

von Bibra H, Tuchnitz A, Klein A, Schneider-Eicke J, Schoemig A, Schwaiger M: Regional diastolic function by pulsed Doppler myocardial mapping for the detection of left ventricular ischemia during pharmacologic stress testing. a comparison with stress echocardiography and perfusion scintigraphy. J Am Coll Cardiol 2000; 36. 444-452

von Rahden BH, Stein HJ, Schmidt G, Bartels H, Overbeck M, Siewert JR: Esophageal cancer surgery in heart transplant patients. Ann Thorac Surg. 2005;80:1510-2

Wacker A, Holder M, Will BE, Winkler PA, Ilmberger J: Comparison of the Aachen Aphasia Test, clinical study and Aachen Aphasia Beside Test in brain tumor patients. Nervenarzt. 2002 Aug;73(8).765-9

Wacker A, Stadler P, Pless M: Chordomas--diagnostic steps and therapeutic consequences. Dtsch Med Wochenschr. 2002 Jun 21;127(25-26).1389-91

Watanabe MA, Alford M, Schneider R, Bauer A, Barthel P, Stein PK, Schmidt G: Demonstration of circadian rhythm in heart rate turbulence using novel application of correlator functions. Heart Rhythm. 2007 Mar;4(3):292-300

Weber S, Ndrepepa G, Schneider M, Deisenhofer I, Zrenner B, Schmitt C: Electrophysiological differences of the spontaneous onset of paroxysmal and persistent atrial fibrillation. Pacing Clin Electrophysiol. 2007 Mar;30(3):295-303

Weber S, Ndrepepa G, Schneider M, Geissler B, Schreieck J, Karch M, Schmieder S, Deisenhofer I, Zrenner B, Schoemig A, Schmitt C: Characterization of onset mechanism and waveform analysis in patients with atrial fibrillation using a high-resolution noncontact mapping system. J Cardiovasc Electrophysiol. 2003;14:176-81.

Weber S, Ndrepepa G, Schneider M, Schmitt C: Two-to-one conduction block between left atrium and right lower pulmonary vein preceding complete vein isolation during radiofrequency current ablation. Pacing Clin Electrophysiol. 2004;27:829-30

Wehinger A, Kastrati A, Elezi S, Baum H, Braun S, Neumann FJ, Schoemig A: Lipoprotein(a) and Coronary Thrombosis and Restenosis After Stent Placement. J Am Coll Cardiol, 1999, 33:1005-12.

Weig HJ, Bott-Fluegel L, Staedele C, Winter K, Schmidt R, Gawaz M, Laugwitz KL, Seyfarth M: Impaired platelet function reduces myocardial infarct size in Galpha(q) knock-out mice in vivo. J Mol Cell Cardiol. 2007 Oct 12

Weig HJ, Laugwitz KL, Moretti A, Kronsbein K, Staedele C, Bruening S, Seyfarth M, Brill T, Schoemig A, Ungerer M: Enhanced cardiac contractility after gene transfer of V2 vasopressin receptors in vivo by ultrasound-guided injection or transcoronary delivery. Circulation 2000; 101. 1578-1585

Weipert J, Noebauer C, Schreiber C, Kostolny M, Zrenner B, Wacker A, Hess J, Lange R: Occurrence and management of atrial arrhythmia after long-term Fontan circulation. J Thorac Cardiovasc Surg. 2004;127:457-64

Werner D, Michalk F, Hinz B, Werner U, Voigt JU, Daniel WG: Impact of enhanced external counterpulsation on peripheral circulation. Angiology. 2007 Apr-May;58(2):185-90

Wessely R: Coxsackieviral replication and pathogenicity: lessons from gene modified animal models. Med Microbiol Immunol (Berl). 2004;193:71-4

Wessely R: Interference by interferons: Janus faces in vascular proliferative diseases. Cardiovasc Res. 2005;66:433-43

Wessely R: Commentary. Evid Based Cardiovasc Med. 2005;9:299-300

Wessely R, Blaich B, Belaiba RS, Merl S, Goerlach A, Kastrati A, Schoemig A: Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug delivery. Thromb Haemost. 2007 Jun;97(6):1003-12

Wessely R, Botnar RM, Vorpahl M, Schwaiger M, Schoemig A, Ibrahim T: Images in cardiovascular medicine. Subacute thrombotic occlusion and spontaneous recanalization of the right coronary artery after percutaneous coronary intervention for ST-elevation myocardial infarction visualized by coronary angiography and cardiac magnetic resonance imaging. Circulation. 2007 Jul 17;116(3):e78-80

Wessely R, Bradaric C, Seybold S: Ruptured vulnerable coronary plaque and Tc-99m sestamibi-based assessment of infarct size. Clin Nucl Med. 2006 Jun;31(6):331-2

Wessely R, Hausleiter J, Michaelis C, Jaschke B, Vogeser M, Milz S, Behnisch B, Schratzenstaller T, Renke-Gluszko M, Stover M, Wintermantel E, Kastrati A, Schoemig A: Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating. Arterioscler Thromb Vasc Biol. 2005;25:748-53

Wessely R, Hengst L, Jaschke B, Wegener F, Richter T, Lupetti R, Paschalidis M, Schoemig A, Brandl R, Neumann FJ: A central role of interferon regulatory factor-1 for the limitation of neointimal hyperplasia. Hum Mol Genet. 2003;12:177-87.

Wessely R, Kastrati A, Mehilli J, Dibra A, Pache J, Schoemig A: Randomized trial of rapamycin- and paclitaxel-eluting stents with identical biodegradable polymeric coating and design. Eur Heart J. 2007 Nov;28(22):2720-5

Wessely R, Kastrati A, Schoemig A: Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent. Ann Intern Med. 2005;143:392-4

Wessely R, Klingel K, Knowlton KU, Kandolf R: Cardioselective Infection With Coxsackievirus B3 Requires Intact Type I Interferon Signalling . Implications for Mortality and Early Viral Replication.  Circulation 103 (2001) 756-761

Wessely R, Pache J, Schoemig A: Recurrence of in-stent restenosis in cardiac allograft vasculopathy following implantation of a sirolimus-eluting stent. Transpl Int. 2005;18:1113-5

Wessely R, Paschalidis M, Wagenpfeil S, Wegener F, Neumann FJ, Theiss W: A comprehensive approach to visual and functional assessment of experimental vascular lesions in vivo. Am J Physiol Heart Circ Physiol. 2004;286:H2461-7

Wessely R, Schoemig A, Kastrati A: Sirolimus and Paclitaxel on polymer-based drug-eluting stents: similar but different. J Am Coll Cardiol. 2006 Feb 21;47(4):708-14

Wessely R, Seidl S, Schoemig A: Cardiac involvement in Emery-Dreifuss muscular dystrophy. Clin Genet. 2005;67:220-3

Wessely R, Vorpahl M, Schoemig A, Klingel K: Late constrictive involvement of the pericardium in a case of previous myocarditis. Cardiovasc Pathol. 2004;13:327-9

Willems S, Eckardt L, Hoffmann E, Klemm H, Pitschner HF, Reithmann C, Tebbenjohanns J, Zrenner B: „Guideline invasive electrophysiological diagnostics“. Clin Res Cardiol. 2007 Sep;96(9):634-651. German

Windecker S, Simon R, Lins M, Klauss V, Eberli FR, Roffi M, Pedrazzini G, Moccetti T, Wenaweser P, Togni M, Tuller D, Zbinden R, Seiler C, Mehilli J, Kastrati A, Meier B, Hess OM: Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization: the TiNOX trial. Circulation. 2005;111:2617-22

Yamane T, Jais P, Shah DC, Hocini M, Peng JT, Deisenhofer I, Clementy J,Haissaguerre M: Efficacy and safety of an irrigated-Tip catheter for the ablation of accessory pathways resistant to conventional radiofrequency ablation. Circulation 2000; 21; 102. 2565-2568

Yamane T, Shah DC, Jais P, Hocini M, Deisenhofer I, Choi KJ, Macle L, Clementy J, Haissaguerre M: Electrogram polarity reversal as an additional indicator of breakthroughs from the left atrium to the pulmonary veins. J Am Coll Cardiol. 2002 Apr 17;39(8).1337-44

Yamane T, Shah DC, Peng JT, Jais P, Hocini M, Deisenhofer I, Choi KJ, Macle L, Clementy J, Haissaguerre M: Morphological characteristics of P waves during selective pulmonary vein pacing. J Am Coll Cardiol 38 (2001) 1505-10

Yano K, Gale D, Massberg S, Cheruvu PK, Monahan-Earley R, Morgan ES, Haig D, von Andrian UH, Dvorak AM, Aird WC: Phenotypic heterogeneity is an evolutionarily conserved feature of the endothelium. Blood. 2007 Jan 15;109(2):613-5

Zielinska M, Andrassy P, Firschke C: Fulminant thrombosis of mechanical mitral valve prosthesis. Heart 86 (2001) E16

Zohlnhoefer D, Brand K, Schipek K, Pogatsa-Murray G, Schoemig A, Neumann FJ: Adhesion of monocyte very late antigen-4 to endothelial vascular cell adhesion molecule-1 induces interleukin-1beta-dependent expression of interleukin-6 in endothelial cells. Arterioscler Thromb Vasc Biol 2000; 20. 353-359

Zohlnhoefer D, Hausleiter J, Kastrati A, Mehilli J, Goos C, Schuehlen H, Pache J, Pogatsa-Murray G, Heemann U, Dirschinger J, Schoemig A: A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib. J Am Coll Cardiol. 2005;46:1999-2003

Zohlnhoefer D, Kastrati A, Schoemig A: Stem cell mobilization by granulocyte-colony-stimulating factor in acute myocardial infarction lessons from the REVIVAL-2 trial. Nat Clin Pract Cardiovasc Med. 2007 Feb;4 Suppl 1:S106-9

Zohlnhoefer D, Klein CA, Richter T, Brandl R, Murr A, Nuehrenberg T, Schoemig A, Baeuerle PA, Neumann FJ: Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy. detection of FK506-binding protein 12 upregulation. Circulation 103 (2001) 1396-1402

Zohlnhoefer D, Nuhrenberg TG, Neumann FJ, Richter T, May AE, Schmidt R, Denker K, Clauss MA, Schoemig A, Baeuerle PA: Rapamycin effects transcriptional programs in smooth muscle cells controlling proliferative and inflammatory properties. Mol Pharmacol. 2004;65:880-9

Zohlnhoefer D, Ott I, Mehilli J, Schoemig K, Michalk F, Ibrahim T,Meisetschlager G, von Wedel J, Bollwein H, Seyfarth M, Dirschinger J, Schmitt C, Schwaiger M, Kastrati A, Schoemig A, REVIVAL-2 Investigators: Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. Jama. 2006 Mar 1;295(9):1003-10

Zohlnhoefer D, Richter T, Neumann F, Nuehrenberg T, Wessely R, Brandl R, Murr A, Klein CA, Baeuerle PA: Transcriptome analysis reveals a role of interferon-gamma in human neointima formation. Mol Cell 7 (2001) 1059-1069

Zrenner B, Dong J, Schreieck J, Deisenhofer I, Estner H, Luani B, Karch M, Schmitt C: Transvenous cryoablation versus radiofrequency ablation of the slow pathway for the treatment of atrioventricular nodal re-entrant tachycardia: a prospective randomized pilot study. Eur Heart J. 2004;25:2226-31

Zrenner B, Gjin N, Schneider M, Karch M, Hofmann F, Schoemig A, Schmitt C: Computer-Assisted Animation of Atrial Tachyarrhythmias Recorded With a 64-Electrode Basket Catheter; J Am Coll Cardiol, 1999, 34: 2051-60

Zrenner B, Ndrepepa G, Karch M, Schneider M, Schmitt C: Block of the lower interatrial connections. insight into the sources of electrocardiographic diversities in common type atrial flutter. PACE 2000; 23. 917-920

Zrenner B, Ndrepepa G, Mussig D, Stobe C, Schneider MA, Karch MR, Plewan A, Schoemig A, Schmitt C: The recording of monophasic action potentials with fractal-coated iridium electrodes in humans. PACE 2000 2354-2362

Zrenner B, Ndrepepa G, Schmitt C: Use of multielectrode basket catheters for mapping of cardiac arrhythmias. Herzschr. Elektrophys 2000 11. 4-10